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Abstract
Due to extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE),
infections among residents are increasing in long-term care facilities (LTCFs), resulting
in high rate of morbidity and healthcare costs. ESBL-PE resists empirical antibiotics and
reduces treatment options, and a designated infection control team is unavailable to
prevent the prevalence of the disease. Ecological theory guided this study. A systematic
review and meta-analysis were conducted to characterize the causes of ESBL-PE and
evaluate the infection control strategies within LTCFs. Multiple regression analysis
(MRA) was included as supplementary statistical analysis to identify relationships
between LTCFs, geographical locations, infection control measures (ICMs), and ESBLPE. A systematic search was conducted for studies from January 2008 to December 2018.
Twenty-two from 3,106 met the inclusion criteria. The pooled prevalence for ESBL-PE
among LTCFs residents was a mean difference (MD) of 15.78 (95% CI: 0.04, 31.53).
Risk factors included the influence of regional areas was standardized mean difference
(SMD) of 0.61(95 % CI: 0.32, 0.91) in Europe, SMD was 14.92 (95% CI: 9.17, 20.68) in
Asia, and SMD was 0.51(95% CI: 0.35, 0.67) in other regions (North America and
Australia). Nine of 22 studies reported ICMs was MD of 13.59 (95% CI: 5.32, 21.86).
Meta-analysis and MRA revealed a statistically significant association between LTCF
and ESBL-PE among residents (p= 0.05). Strict adherence to infection control measures
in LTCFs is needed to address this ESBL-PE prevalence among residents. The potential
positive social change is promoting knowledge about vulnerable residents in LTCFs and
the community factors responsible for ESBL infection.
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Chapter 1: Introduction to the Study
Introduction
Long-term care facilities (LTCFs) serve as a different type of health care
setting that provides a certain level of care services for individuals of all ages. The
facilities have been increasingly caring for a broader range of residents who need
exceptional healthcare services. LTCFs include nursing homes, assisted living facilities,
residential care homes, skilled nursing facilities, and domiciliary care homes, etc. The
facility homes serve as home and health institutions for approximately 75% of older
adults and individuals with intellectual disabilities (Johansson et al., 2017). Despite the
caring nature of these facilities, it also, however, provided a unique setting for
sharing infections within residents and between health care facilities via workers who
work in more than two care homes (Curran, 2017). Essential types of diseases commonly
transmitting in LTCFs include urinary tract infection (UTI), respiratory tract
infection (RTI), skin and soft tissue infection, and gastrointestinal infection (GI)
(Montoya & Mody, 2011). Notably, about 94% of these diseases are found in
LTCFs (Cotter et al., 2012; Heudorf et al., 2012). The infections may be caused by
pathogens associated with community-acquired infection or hospital-acquired infection;
for example, Enterobacteriaceae species is an essential cause of several of these diseases
(Cassone & Mody, 2015). In a study conducted by Pop-Vicas et al. (2008), the
researchers observed a colonization rate of 51%. These isolates included Escherichia
coli, Klebsiella pneumonia, Morganella morganii, Enterobacter species, Proteus
mirabilis, and Providencia stuartii. The study also indicated that risk factors that caused
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pneumonia were due to Enterobacteriaceae multidrug-resistance organisms because most
of the residents have already exposed to the past six months’ uncontrolled use of
antibiotics as well as low activities of the daily living score. The rapid dissemination of
these infections is severe and can resist multiple drugs, which was considered as one of
the main threats to global public health with no sign of abating (Kaarme et al., 2018). The
severe modes of these diseases are more evident in elderly residents because of their
prolonged exposure to risk factors, already mentioned above, which has been evaluated
by most studies as one of the significant risk factors of chronic diseases caused by
Enterobacteriaceae (Pulcini et al., 2019). For example, older people in LTCFs in France
were investigated to have a risk of about 40% higher than their domiciliary elderly clients
in the community of having antibiotic resistant Enterobacteriaceae cultured from their
urine samples (Pulcini et al., 2019). The risen of Enterobacteriaceae species occur in a
multidrug resistance isolates because of their intent to distribute, acquire additional
resistance enzymes, and exhibit complications in the therapeutic management of infected
patients, particularly in vulnerable elderly ill patients (Shaikh et al., 2015). More often,
these Enterobacteriaceae produced extended-spectrum beta-lactamases, beta-lactamaseinhibitor-resistant TEM enzymes, and stably derepressed plasmid-encoded AmpC
cephalosporinases (Tsukamoto et al., 2014). The isolates are also characterizing with
cross-resistance to aminoglycosides and fluoroquinolone with high mortality and
morbidity (Tsukamoto et al., 2014). Even the emergence of Enterobacteriaceae species
that resist carbapenem types of antibiotics in most communities is sporadically making
the treatment of elderly residents so difficult (Gohil et al., 2017). Residents whose care
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needs devices like breathing machines, catheters, or intravenous catheters and residents
who are taking long courses of certain antibiotics are also most at risk for Extended
spectrum beta-lactamase (ESBL) infections and carbapenem-resistant Enterobacteriaceae
(CRE) infections (Centers for Disease Control and Prevention [CDC], 2015). Because of
the sizable number of Enterobacteriaceae species involved, this dissertation concentrated
on the most common genera and species isolated from clinical settings, include,
Escherichia coli, Klebsiella pneumonia, and Proteus mirabilis, Serratia marcescens,
Citrobacter species, and Enterobacter species accounted for the majority of
Enterobacteriaceae isolated from clinical specimens. This study is significant because
Enterobacteriaceae accounted for a high proportion of infection among residents living
in LTCFs in the United Kingdom (UK) and the entire world was a great concern (Public
Health Agency, 2019) on how to reduce the spread of the disease. Extended spectrum
beta-lactamase producing Enterobacteriaceae (ESBL-PE) have limited treatment
alternatives and thus endangering a more significant number of patients and residents
(Weiner, 2016). The CDC and World Health Organization (WHO) considered ESBL-PE
infection as severe threats and recognized the organism as an urgent concern for drug
development (Tacconelli et al., 2018; WHO, 2017). The study provided significant
insights into Enterobacteriaceae resistance patterns and informing public health,
infection control, and antimicrobial stewardship approaches to curb the spread of the
emerging pathogens. The objective of this systematic review and meta-analysis was to
justify the causes of prevalence and control measures of ESBL-PE in LTCFs. The reasons
for writing this dissertation were to contribute to knowledge of outbreaks among elderly

4
residents in LTCFs and be able to find a solution to research questions generated for this
dissertation.
Background
Antimicrobials are used to treat infections of various diseases caused by
microorganisms, including bacteria, mycobacteria, viruses, parasites, and fungi (WHO,
2016). Since the discovery of the modern era of antibiotics by Sir Alexander Fleming in
1928 (Piddock, 2012; Sengupta et al., 2013), the transformation of contemporary
antibiotic medications that saved millions of lives (CDC, 2013), and the difficulties in the
management of antibiotic resistance microorganisms globally, the phenomena are,
however, endangering the efficacy of the power of antibiotics (Golkar et al., 2014). In
most clinical and public health cases where antibiotics are used, the microbes initiated a
means to make antibiotic agents ineffective. Under these circumstances, resistance
develops anywhere antibiotics are used, including the community, healthcare, and on the
farm (Prestinaci et al., 2015). The microorganisms that caused resistance had always been
attributed to the inappropriate prescription or misuse of antibiotic drugs and the inability
of the pharmaceutical industry to produce new medication due to the challenging
regulatory requirements (Michael, 2014). Based on this characterization, the CDC has
classified some multidrug Enterobacteriaceae resistance microorganisms responsible for
placing a significant clinical and financial burden on the global healthcare system,
patients, and their families (CDC, 2018). These Enterobacteriaceae species are crossresistance because they produce ESBL enzyme not only to hydrolyze beta-lactam ring of
penicillin and third generation-cephalosporins (TGCs) but also inactivating quinolone
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and aminoglycosides. These organisms have caused approximately 26,000 healthcareassociated (HCA) infections per year in the USA (CDC, 2018). Also, it was estimated
that 140,000 HCA Enterobacteriaceae infections occur in the United States every year,
resulting in bloodstream infections that result in more than $40,000 hospital charges per
occurrence (CDC, 2018). However, the threat of this disease is no more limited to the
hospitals; it is also a threat to elderly residents in LTCFs (Public Health England, 2016).
Pelly et al. (2006) study described nursing homes as a proxy and closed living quarters
that could contribute to antibiotic-resistant infections and probably had a relationship
with the occurrence of ESBL-PE infection among the residents in the LTCFs (Blom et
al., 2016). These ESBL-PE have been consistently inflicted on nursing home residents in
the United Kingdom and other parts of the world (Blane et al., 2016). Traditionally.
ESBL-PE was associated with hospital settings, but more recent studies have also shown
increasing isolation of ESBL strains in the community-based long-term care settings
(Flokas et al., 2017; Livermore et al., 2005). Nursing, residential care homes, and other
LTCFs have been suggested to be a reservoir for ESBL-PE in the community (Arpin et
al., 2003; Rice et al., 1990; Rooney, 2009). Cefotaxime producing (CTX-M) Escherichia
coli was first reported from Ireland in 2005 (Morris et al., 2005) and was associated with
the LTCFs outbreak, soon afterward in 2006 (Pelly et al., 2006). Most of these elderly
residents repeatedly at risk of acquiring ESBL-PE because they were often exposed to
excess use of antibiotics, previous hospital admission, incontinence, urinary catheters,
and decubitus ulcers (Overdevest et al., 2016). Research indicated that there were several
approaches to analyzing risk factors and the prevalence of Enterobacteriaceae that
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produces ESBL enzyme in the community where LTCFs are located. In laboratory
surveillance of Enterobacteriaceae (Public Health England, 2017), the trends and
geographical distribution of Enterobacteriaceae species rates were reported. Even cases
of these infections were further broken down by bacterial species and by patient age and
sex. However, the prevalence of the trends of ESBL-PE colonization differed
significantly across the LTCFs (Lautenbach et al., 2012). In one observational study
(Sandoval, 2004) of ESBL-PE towards the residence in LTCFs, the research was focused
explicitly on resident’s early exposure to cephalosporins because of their prior extended
stay in the hospital coupled with the increased use of gastrostomy tubes in the care home,
of which, resulted in the occurrence of Enterobacteriaceae resistance to third-generation
cephalosporins. Rooney et al. (2009) also reported that residents were colonized with an
extremely high prevalence of multidrug resistance Enterobacteriaceae of gut carriage of
residents. As noted by each assessment, all the above-mentioned research methods
provided credible and logical results. The gaps in the above-highlighted research were
unable to give reasons for the significant differences in the prevalence of the trends of
ESBL-PE colonization across the sites. The objective of this dissertation was to conduct a
systematic review and meta-analysis to identify the causes and risk factors associated
with the prevalence of ESBL-PE from the pool evidence and to identify effective control
measures for curbing the pathogen. Considering the current knowledge of the
epidemiology of ESBL-PE infections in LTCFs, it is, however, poorly understood the
incidence of the disease as well as control measures involved. The study is focusing on
the assessment of the infection control measures for the prevention of ESBL-PE in
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LTCFs, and the data collected from 2008 to 2018 was explored to clarify the measure of
the distribution of ESBL-PE and effective infection control in these facilities and
informed clinical and public health awareness of this growing problem.
Problem Statement
Enterobacteriaceae that produce extended-spectrum beta-lactamase (ESBL)
convey plasmid-encoded enzymes that can effectively dissolve and confer resistance to a
variety of beta-lactam antibiotics (Shaikh et al., 2015). Although, in Europe, these
enzymes are mostly found in Escherichia coli (ECO) and Klebsiella pneumonia
(KLP), they also present in other members of the Enterobacteriaceae (Rawat & Nair,
2010). The rise and transmission of ESBL-PE is a public health threat because they
associated with increased morbidity, mortality, and healthcare costs (Rawat & Nair,
2010). Arpin et al. (2003) and Duval et al. (2019) suggested that nursing homes and other
LTCFs have been placed as a reservoir for ESBL-PE in the care homes. Most of these
residents are repeatedly a risk of acquiring the infection because they were often exposed
to unguided use of antimicrobial, previous hospital admission, incontinence, urinary
catheters, and decubitus ulcers (Feneley et al., 2015; Nicolle, 2014). Because ESBL-PE is
associated with poor patient outcomes, control the transmission of these infections
in LTCFs after their acquisition is essential to curb further spread in areas where they
have become endemic (Flokas et al., 2017). Effective identifying infection control
measures is an essential step to prevent residents from becoming colonized or infected
with these infections. Although some LTCFs have addressed the spread of ESBL-PE by
creating new strategies to curb the spread, they do not have a designated infection control
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practitioner compared with the hospital set-up (Cohen et al., 2015). To control the spread
of ESBL-PE in nursing homes, the CDC approved the use of personal protective
equipment (PPE) to prevent blood and body fluids split and during high-contact resident
care activities (e. g. dressing, bathing/showering, and transferring) that provided
opportunities for transfer of ESBL-PE to staff's hands and clothing (CDC, 2019). This
systematic review and meta-analysis aim to identify from all available evidence the
causes of ESBL-PE prevalence and the efficient use of infection control measures to
reduce or stop the spread in LTCFs. The summary of this evidence may be used by
LTCFs to develop guidance on this topic and help to control the dissemination of ESBLPE within residents and between health care facilities via workers who work in more than
two care homes.
Purpose of the Study
Long-term care facilities serve a different type of health care settings that cares
for individuals of all ages and provides a certain level of care services. The facility homes
also serve as home and health institutions for most older adults and individuals with
intellectual disabilities (Johansson et al., 2017). Despite the caring nature of these
facilities, the facilities also provided a unique setting for sharing multidrug resistance
organisms (MDROs), such as ESBL-PE infections within residents and between health
care facilities via workers who worked in more than two care homes (Curran, 2017).
These organisms can curse urinary tract infections, as well as severe infections in the
bloodstream and central nervous system. Numerous journals have conducted research on
these MDROs with different methods of controlling the infections without much success.
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The purpose of this study is to use systematic review and meta-analysis to identify,
evaluate, and compile the findings of all relevant individual studies on the causes of
the prevalence and control of ESBL-PE in LTCFs and the evidence for the effectiveness
of infection control and prevention strategies. The intervention measures are aimed at
preventing and controlling the spread of ESBL-PE in elderly care homes, especially when
residents are in a debilitating health condition or transferred from the hospital. The
examination of ESBL-PE outbreak within elderly resident homes permitted this research
to present the evidence about the role of targeted or non-targeted infection control
interventions, which includes screening tests in the etiology of ESBL enzymes in LTCFs.
The study identified the effective control measures applied against the prevalence of
ESBL-PE in LTCFs of previous research. I developed the search strategy for the
publications which are published from 2008 to 2018 from at least two electronic
databases like PubMed/Medline, Embase, and Cochrane by using the following terms:
extended-spectrum beta-lactamase-producing Enterobacteriaceae long term care
facilities or ESBL-PE long term care facilities or ESBL-PE long term care facilities and
infection control long term care facilities or infection prevention long term care
facilities. I screened the search records based on title and abstract through a screen called
First Pass Screening (FPS), which was retrieved through databases against the predefined
eligibility criteria. Quality assessment based on study design of included studies were
evaluated using New Castle Ottawa Scale for observational study. Statistical analyses
were performed using the ‘‘Cochrane RevMan’’ statistical software program. The metaanalysis of categorical data was analyzed, and pooled the estimates, and presented as
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analysis of continuous data was analyzed, and pooled the estimates, and presented as
Mean Difference (MD) along with their 95% confidence intervals (CIs). I also performed
a subgroup analysis based on region, ICMs etc., to find the heterogeneity.
Research Questions and Hypotheses
The study was conducted to gain insights into the occurrence and characteristics
of ESBL-PE infections among elderly residents in LTCFs reflected in the relationships
between variables under study. Because of the type of LTCFs, the geographical location
of LTCFs, effective infection control measures, and ESBL-PE infection rates. Based on
this information, the research questions mentioned below are relevant to be addressed:
Research Question 1: Is there an association between LTCF and the prevalence of
ESBL-PE infection rates among residents in the presence of other predictors?
H01: There is no association between LTCF and ESBL-PE infections in the
presence of predictors.
Ha1: There is a significant association between LTCF and ESBL-PE infections in
the presence of other predictors.
Research Question 2: Is there an association between geographical locations
(environmental sources) and ESBL-PE in LTCFs in the presence of other predictors?
H02: There is no association between geographical locations (environmental
sources) and ESBL-PE infections in the presence of predictors.
Ha2: There is a significant association between geographical locations
(environmental sources) and ESBL-PE infections in the presence of other
predictors.
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Research Question 3: Is there an association between Infection Control Measures
and ESBL-PE infections?
H03: There is no association between infection control measures and ESBL-PE
infections in the presence of predictors.
Ha3: There is a significant association between infection control measure and
ESBL-PE infections in the presence of other predictors.
Theoretical Framework
The ecological theory was used as a construct for this research. The theory can
detect and improve infection control and public health policy (Smith et al., 2005).
Currently, there were three overlapping conceptual frameworks that have been
dominating the study of the emergence and dissemination of infectious disease since
decades ago. This overlapping framework only focuses on pathogen infecting a single
patient over the population, and researchers thus developed a drug that cures individual
patient (Smith et al., 2005). From an ecological context, the risk factors of diseases often
emanated from the collection of population and the environment. But the ecological
theory used population genetics and dynamics approaches to understand and predict the
prevalence of infectious disease that informed patient treatment (Smith et al., 2005). In
this concept, the ecological approach was used to provide details on LTCF types,
geographical location, demographic of residents in the facilities, and the effective
infection control measures and the occurrence of Enterobacteriaceae organisms,
including Enterobacteriaceae that produces ESBL enzymes. The term “LTCF” refers to
any different types of care homes which provide broad range of healthcare services to
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people with limited ability to respond to action independently (European Centre for
Disease Prevention and Control [ECDC], 2016). Each type of LTCFs, or geographical
location of LTCFs may have similar risk factors to residents with different outcome
variables in the following research questions: (1) Is there an association between LTCF
type and the prevalence of ESBL-PE infection rates among residents in the presence of
other predictors? (2) Is there an association between environmental sources and ESBLPE in LTCFs in the presence of other predictors? (3) What are the essential components
of effective infection control in preventing LTCFs outbreaks? Under these circumstances,
the epidemiological construct was used to detect risk factors for the occurrence of ESBLPE isolates and preventing residents from these infectious diseases in all types of LTCFs.
The ecology theory has achieved various development in the prevention and control of
infectious diseases around the world. Because of this theory, public health institutions
and Non-governmental organisations (NGOs) were loaded with the design and
maintenance of health programs and capitalized on the insights provided by ecological
theory to prevent and control infectious diseases (Smith et al., 2005). The theory has used
host demography and distribution to predict the emergence of infectious diseases. In this
theory, ecological and evolutionary dynamics has been used to predict pathogen–host
shifts (Smith et al., 2005), and determining effective and efficient allocation of resources
to disease surveillance.
The Nature of the Study
The study was based on a descriptive literature review and meta-analysis of the
published and unpublished studies from 2008 to 2018, investigated the prevalence of
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ESBL-PE infection in LTCFs, and to identify infection control measures used to reduce
the spread. The statistical analysis of combines results of multiple studies on Infection
control measures on transmission of ESBL-PE in LTCFs was succinctly examined to
answer the research questions. The dissertation was registered with the Preferred
Reporting Items Systematic Reviews and Meta-Analysis (PRISMA) guidelines to prevent
risk of numerous articles addressing same research questions, reduce bias in accumulated
publications, and to provide transparency in the study (National Institute for Health
Research [NIHR], 2019). I ensured that all steps of the review process conform to
published systematic review designs as recommended in the Cochrane Handbook and
Centre for Reviews and Dissemination's (CRD) guidance for conducting systematic
reviews. I included all studies involved all designs investigated an infection control
intervention for patients admitted in LTCFs who were at risk of becoming infected with
ESBL-PE. This study was influenced by the information that I obtained from the
databases. I created a list of keywords related to my research topic and research
questions to search for published and unpublished literatures. Some useful databases were
searched for journals and articles from January 2008 to December 2018, and these
included Walden University’s library catalogue, Medline, Google Scholar, Ebsco
Embase, Cinahl, and bibliographies of identified research and reviewed articles were
checked further for more studies. I have been cleared by Walden University IRB to
review and synthesize data from unpublished and published studies.
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Definitions
The definitions used in this research are intended to help readers understand the
clinical and scientific concepts, allowing clarity in the meaning of the terms within the
study's context to clarify the purpose and direction of the investigation being conducted.
Cephalosporins refer to a class of antibiotics originally derived from the fungus
called Acremonium, which was previously known as "Cephalosporium" Toai Bui;
(Charles V. Preuss).
Extended-spectrum beta-lactamases (ESBL) are enzymes that cause resistance to
most beta-lactam antibiotics, including penicillin, cephalosporins, and the monobactam
aztreonam. These enzymes are found exclusively in gram-negative organisms, such as
Klebsiella pneumonia, Klebsiella oxytoca, and Escherichia coli.
Long-term care facilities (LTCFs) represent a different type of health care settings
that serve individuals of all ages and provide variable degrees of care. Examples of
LTCFs include nursing homes, skilled-nursing facilities providing post-acute care,
assisted living facilities, retirement homes, rehabilitation centers,
Drug-resistant gram-negative organisms refer to resistance of microorganisms to
three or more different antimicrobial classes.
Enterobacteriaceae refers to a large family of Gram-negative bacteria including
E. coli, Klebsiella species and Proteus species.
CTX-M beta-lactamases — These enzymes were named for their greater activity
against cefotaxime than other oxyimino-beta-lactam substrates (for example, ceftazidime,
ceftriaxone, or cefepime).
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Assumptions
The first assumption is that the meta-analyses sum up a few evidence-based
articles to examine ESBL-PE prevalence and effective infection prevention measures
in LTCFs. The second assumption is that systematic collections of evidence-based
journals from the databases like PubMed/Medline, Google Scholar, Embase, and
Cochrane for the analysis are reliable and valid. These databases are reliable because it
resulted in almost the same search outcomes if it was searched whenever searching the
exact keywords. After writing the theoretical foundation of my study, I assumed that my
study's foundation is sound. This ecological conceptual framework is a concept that has
been tested and proven to prevent or control diseases in the communities in previous
research. The theoretical framework that I used is assumed to be an accurate reflection of
the systematic review and meta-analysis of prevalence and effective control of ESBL-PE
in LTCFs being studied. Therefore, my study results were limited by the theoretical
framework's accuracy to reflect the phenomena under study. The fourth assumption is
recognizing ESBL enzyme producers among Enterobacteriaceae species, confirming
ESBL Production through a combination disc method in the laboratory. The ESBL-PE
under investigation and finds have been clearly defined, and it is being measured in
accredited laboratories. So, I assumed that any documents collected via public databases
contained the information necessary to draw valid and reliable conclusions. I conducted a
systematic review and meta-analysis; I believed that I was unbiased in reporting what I
observed. I also assumed that the variables under investigation are measurable, and the
instrument used is valid and reliable instrument to measure those variables. Importantly, I
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assumed the methodology used in this research was suitable to the problem being
addressed and the purpose of the study. I completed my analysis, and I assumed that the
results are generalizable beyond the sample collected for studies. Finally, I assumed that
the results of the study were appropriate to stakeholders.
Scope and Delimitations
The study's scope is limited to Enterobacteriaceae species microorganisms
among residents in LTCFs in a systematic review and meta-analysis approach. One of the
aims and objectives of this research is to reduce the spread of microbes among residents
in LTCFs. This research has begun with what we are already known about ESBL-PE,
what would be added to the topic's synopsis, and the significance for public health
practice. I investigated the trends of ESBL-PE and determined their variations according
to the types of LTCFs. Residents who were exposed to cases of ESBL-PE introduced by
LTCFs. Irrespective of gender, age, and ethnicity. Targeted or non-targeted infection
control interventions that included screening tests were employed to determine the
infection control level. Standard precautions or placebo screening are used as a
comparator. Incidence or frequency of infection was used to assess transmission or
spread of ESBL-PE within residents in LTCFs with the outcome of morbidity and
mortality rate. Studies that did not report data on acquisition outcomes were excluded
from the scope of this research. The research only involved the literature on randomized
controlled trials and observational studies. I developed the search strategy for at least two
electronic databases like PubMed/Medline, Embase, and Cochrane by using key search
terms: The publication period that lasts for ten years, that is, publications published from
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2008 to 2018 were investigated. Journals that are published before 2008 and after 2018
were excluded. The variations of the organisms were identified according to the species
and their susceptive character. The mechanisms susceptive nature of Enterobacteriaceae
species in the production of ESBL enzymes that resist third generation-cephalosporins
were evaluated. I provided some context to this review, outline the medical significance
of ESBL-PE mostly affected LTC residents, highlight the implications of managing the
diseases before it confers resistance to universally used empirical beta-lactam antibiotic
therapy. A brief description of ESBL-PE distribution was provided, including a
discussion on susceptible antibiotic patterns, the development of ESBL among residents,
and the mechanisms of ESBL. Notably, a brief detail of the current situation of the
medical significance of Enterobacteriaceae surveillance in LTCFs was provided, and the
key areas for developing effective control and prevention of the disease was highlighted.
I discussed the development of ESBL among residents in LTCFs, including the
mechanisms of ESBL and the susceptible antibiotic patterns of the pathogens. I
investigated the reasons for differences in the trends of ESBL-PE colonization across the
different types of LTCFs, understanding if there is an association between the
geographical location of LTCFs, targeted infection control, and the occurrence of ESBLPE infection among the elderly residents. The evidence base for the essentials of ESBLPE surveillance was discussed with the status of the clinical importance of
Enterobacteriaceae surveillance in global health. In this analysis, I highlighted the
crucial areas for preventing ESBL-PE among the residents in different types of LTCFs. I
conducted a high-level systematic review of ESBL-PE scholarly studies to proffer public
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health solutions to the research questions mentioned above. I used a systematic review to
identify, selects, evaluates, and synthesizes all high-quality research evidence relevant to
the research questions to answer them. Besides, I provided evidence-based insight to
describe the potential source of ESBL-PE infection between resident's LTCFs. Also. I
used a systematic review to review information from both published and unpublished
studies relating to infection control strategies in LTCFs. In a meta-analysis of this review,
I used statistical methods, Comprehensive Meta-Analysis (CMA) software to incorporate
data from the investigated individual research studies, used the combined information to
come to new statistical conclusions by selecting, evaluating, and synthesizing all
available evidence.
Limitations
This research seeks to identify and sum up the findings from the eligible available
evidence to establish the relationships between ESBL species' trends among residents in
LTCFs, their variations according to the types of LTCFs, and to identify effective
infection control measures. However, the methodological quality of systematic review
and meta-analysis studies often restricts the study's scientific value because of the studies'
heterogeneous nature. In this study, I intend to limit my analysis to the included data to
represent the best available evidence. The studies examined during an outbreak always
take up inadequate methodologies in assessing the efficacy of the infection prevention
measures introduced. The methods of pre, during, and post enforcing prevention
measures of incidence or prevalence of ESBL-E design, such design is likely to be
subjected to some biases, including the risk of confounding. I also intended to examine
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groups of targeted and untargeted infection control measures, including screening at a
single time point. Only infection prevention measures that changed between the pre- to
post-infection prevention measure periods are likely to be considered associated with any
change in ESBL-PE prevalence in LTCFs. Under these circumstances, it may be difficult
to measure or determine the reasons responsible for the observed effects likely to be
poorly reported in many available data. However, the interventions are part of a
collection of measures that cannot be examined in isolation. Furthermore, compliance
may be poorly reported in some studies implementing infection control. In this study,
external circumstances played a role in compliance and enforcing infection prevention
measures. For instance, an improvement in compliance can be due to the presence of a
known observer, known as the 'observer effect,' a well-documented effect for infection
prevention measures, such as hand hygiene. The data intended to be retrieved for this
research could be heterogeneous, especially concerning locations, populations, outcomes,
outcome evaluation techniques, and infection control measures, precluding quantitative
analysis. The low reporting quality may impede the investigation of these studies.
However, the reporting guidelines can be readily available to correct the anomaly. For
instance, the 'Outbreak Reports and Intervention studies of Nosocomial infection'
(ORION) statement are useful reporting guidelines.
Significance
The dissertation is not only significant to the recent release of the UK five-year
antimicrobial resistance strategy from January 2014 to December 2018 (Global and
Public Health Group, 2017) but also aligning with the public health agency aims and
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objectives of establishing Healthcare-Associated Infection and Antimicrobial
Stewardship Improvement Board of 2016 in Northern Ireland. The development of this
Board is a process of preventing gram-negative Enterobacteriaceae infections in public
and private care homes through antimicrobial stewardship and infection control initiatives
(Global and Public Health Group, 2017). Furthermore, during the global action plans in
2015, the World Health Assembly called all countries to execute national antimicrobial
resistance strategies to tackle multidrug-resistant organisms by strengthening surveillance
and research. This research aligns with that objective (World Health Organization, 2015).
However, the multisectoral collaboration has been emerged to organize its systems to
achieve effective action against the spread of MDROs such as ESBL, which can be
interpreted into practice (Wesangula & Hickey, 2018). Firstly, the rationale for
undertaking this research is to contribute to the evidence base of knowledge on the risks
and prevalence of ESBL in LTCFs. The informed knowledge provided data estimates of
resistance to commonly used antibiotics (cephalosporins) to treat Enterobacteriaceae
species and identify the organisms' trends in the LTCFs. The significance of this study
may also justify reconsidering use of carbapenem antibiotics for residents in
LTCFs, where it is recommended as the last option choice for Enterobacteriaceae that
resist cephalosporins in the treatment of many diseases (Patterson & Bradley,
2017; Rodríguez-Baño, Gutiérrez-Gutiérrez, Machuca, & Pascual, 2018), and making
corrections for antibiotics stewardship strategies to prevent occurring of carbapenems
producing Enterobacteriaceae. The other significance of this study is the potential
outcomes to inform decisions on residents' treatment with diseases caused by ESBL-PE. I
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also used the study to identify the reasons for the significant differences in ESBL
colonization trends across all the sites and understand relationships between the
environmental differences risk factors of LTCFs and ESBL-PE occurrence. Importantly,
however, the study helped reveal the underlying presence of ESBL infection in LTCF
settings and improve healthcare policymakers to evaluate strategies of reducing the
prevalence of this infection. Thirdly, the findings of variables correlated with ESBL
infection were identified and contributed to effective infection control knowledge. The
study identified the trends of associated risk factors with ESBL infection in these
facilities and around the residents, thereby invoking regional or county infection
prevention efforts. Although the implications of ESBL are obvious in healthcare
facilities, the most significant ESBL-PE are occurring in the community, which directly
and indirectly affecting public and private care home residents (Rodríguez-Baño et al.,
2018). Comparing ESBL within and between types of LTCFs and community-acquired
infection may provide enough data to make infection control policy and antibiotic advice
for ESBL infections on-site of acquisition. This research's fourth significance is the
potential to offer comprehensive information on residents' environmental risk factors
associated with ESBL infection and use this information to determine resistance and
susceptibility patterns of Enterobacteriaceae species by different geographical locations
LTCFs to identify substantial hidden differences from the data collected for the research.
The community-related variables such as the geographical location of the LTCFs and
types of the facilities may have been unknowingly associated with the communityacquired infection and resulted in the prevalence and severity of diseases caused by
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ESBL-PE among the residents living in LTCFs. The fifth essential of this research
contributed to improving the quality of surveying on ESBL-PE in LTCFs residents,
especially their health status, by re-evaluating and redetermining variables that may result
in the introduction of the disease caused by these bacteria. The assessment of these
isolates' trends and their antimicrobial susceptibility data would be essential to infection
control teams, physicians, and clinical researchers to treat residents in LTCFs with no
difficulties. The UK government forced all regions to implement a five-year
antimicrobial resistance strategy from 2013 to 2018 (Global and Public Health Group,
2017) to reduce the life-threatening ESBL-PE species in hospitals and long-term care
patients. Its significance is that it outlines the UK antimicrobial action plans to slow the
growth and spread of these diseases, focusing on ESBL-PE, which was the top three spots
of the deadly disease on the World Health Organization (WHO) lists. These studies'
outcomes furnished comprehensive information on ESBL-PE trends, their antibiotic
susceptibility, and resistance patterns among long-term care residents in the analysis. The
knowledge of this analysis would invoke an action towards the development and
implementation of ESBL multidrug resistance control policies, identifying areas for
interventions, and essential to inform the treatment guidelines for infections caused by
these microbes both in the UK and rest of the world. The potential positive social change
resulting in this research could promote knowledge about vulnerable residents in public
and private LTCFs and community factors responsible for ESBL infection. As we
promote awareness for the residents in LTCFs, the care sites at most risk could take
further steps to reduce the risks of infecting the subjects.
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Summary
Enterobacteriaceae are part of healthy bowel flora but can be pathogenic
depending on the site of infection. Despite the pathogenic character of the
microorganism, the dissemination of multidrug-resistant Enterobacteriaceae related to
the production of ESBL is also a public health concern throughout the world. In this
dissertation, I analyzed data from the public databases to determine the risks and
prevalence of ESBL-PE among residents in LTCFs from January 2014 to December
2018. These organisms are thought to be associated with morbidity and mortality and
have contributed to the rising burden in public and private healthcare settings across older
adults and demographics. Through this research, I identified the relationship of each
independent variable to the dependent variable. The study identified risks other than the
excessive use of antibiotics and new ways to interpret prior research. From the significant
points of this dissertation, I revealed gaps in the literature that need to be investigated and
resolved conflicts between transmission of ESBL-PE among residents and infection
control measures. Because of the pathogenic nature of Enterobacteriaceae, I proposed to
analyze the trends of Enterobacteriaceae species and to determine their variations
according to the geographical location of LTCFs. The dissemination of multidrugresistance Enterobacteriaceae related to the production of ESBL, and their susceptible
antibiotic patterns were discussed in detail. The fundamental reasons for the differences
in ESBL colonization across LTCFs and their association with community variables were
developed and researched among the residents. I exploited a high-level systematic review
was conducted on controlling transmission of ESBL-PE between the LTCFs types. The
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dissertation investigates the risks causing the prevalence of ESBL-PE in LTCFs, and the
effective infection control measures applied.
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Chapter 2: Literature Review
Introduction
This chapter provides a detailed discussion of the literature related to the present
meta-analytic study's content investigating causes of the prevalence and control measures
of Extended Spectrum Beta-Lactamase producing Enterobacteriaceae (ESBL-PE) in
Long-Term Care Facilities (LTCFs). It explores explicitly research that informs efforts to
introduce effective infection control measures against ESBL-PE infection in LTCFs.
Several studies have examined the prevalence of ESBL-PE in both hospital and LTCFs
and the application of infection control measures since disease discovery. ESBL-PE was
identified in the 1960s in Greece as an aggressive hospital and community-acquired
infections. The infections have currently spread worldwide (Doi et al., 2017), resulting in
increased morbidity and mortality (Huang et al., 2018; Melzera & Petersen, 2017).
Transmission of these microorganisms from colonized or infected residents to other
residents or other hospital patients does always occur through healthcare personnel's
hands and transferring hospitalized patients from their long-stay to community-based
nursing homes (Hughes et al., 2013). In a study by Flanagan, Cassone, Montoya, and
Mody (2016), the report was that transferring sick residents between hospitals and
nursing homes created unnecessary, exposing residents to colonization and infection risk.
Because of these risk factors, sometimes, residents always prefer to be treated at the care
home to avoid contact with the disease. In a study of Bush (2010), I found that isolates
that convey resistance to the cephalosporin indicators in first-line antibiotic panels of
testing clinical importance Enterobacteriaceae may represent a particular risk to a
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resident in nursing homes, and obtainable in the considerable high ESBL-PE colonization
rates among elderly patients discharged from hospitals and transferred to the nursing
homes (Hughes et al., 2013). Once the residents settled in the nursing home, the possible
spread of ESBL-PE within and between residents may occur. This can result in increased
colonization of the disease within the nursing home (Rooney et al., 2009) and result in
further hospital-onset infection when the residents needed to be hospitalized again
(Thaden et al., 2016). Studies have indicated that nursing homes are a suitable and unique
environment for residents to receive an extensive range of acute care. These include the
provision of medicine, dressing, washing, and taking residents to the toilet, often
resulting in the acquisition, and spread of ESBL-PE (Doi et al., 2017; Rooney et al.,
2009). The reasons are that the residents have debilitated illness, multiple exposures to
antimicrobial agents, and indwelling apparatus. However, many of them are prone to
have the risk of ESBL infection (Sandoval et al., 2004). In one study, there was an
increase in ESBL-PE colonization in the nursing homes that may increase ESBL
colonization in the hospital because of transferring long-stay hospitalized residents to
community-based nursing homes (Hagel et al., 2019). Based on currently available
evidence provided by Smith et al. (2008) studies, the Association for Practitioners in
Infection Control, and the Society for Hospital Epidemiology (APICSHE) guidelines is
used as a standard of preventing and controlling infection between nursing homes and
hospital. Unfortunately, recruiting personnel and support for infection control in LTCFs
are still lagging (Curran, 2017; Mody et al., 2005; Roup et al., 2006) due to the
challenges of inadequate implementation of infection control policies to infection control
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in these facilities (Smith et al., 2008). There are various types of infection in LTCFs that
are frequently affecting residents. These include urinary tract infection (UTI), respiratory
tract infection (RTI), skin infection, soft tissue infection, and gastrointestinal infection
(Montoya & Mody, 2011). The mechanisms by which these diseases are spreading
represented approximately 94% of conditions observed in LTCFs and hospitals (Cotter et
al., 2012; Engelhart et al., 2005; Heudorf et al., 2012; Pop-Vicas et al. 2008), which
constitute an uncontrollable infection in both hospital and community settings. In this
dissertation, I used systematic review and meta-analysis to examine the relationship
between ESBL-PE in LTCFs and infection control measures. Infection control measures
to prevent transmission of ESBL-PE among residents in LTCFs is essentially needed. All
these microbes can present a challenge for healthcare practice if not adequately
controlled. However, little is known about these organism's impacts within and between
the long-term care facilities. Cochrane Collaboration described the systematic review as a
method of collating all evidence-based peer-reviewed related articles that fit eligibility
criteria studies to answer research questions (Higgins & Green 2011). I implemented the
Cochrane approach with clear-cut objectives, transparency, and unbiases to appraise and
synthesize all related literatures specific to the research questions. Moreover, having
combined and summarized the results of primary studies, I used the meta-analyses
technique using statistics to estimate the outcome of the study population described above
by investigating the strengths and weaknesses of the current literature on ESBL-PE
infections. I used the systematic review and meta-analyses to appraise the infection
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control measures to prevent ESBL-PE transmission in LTCFs by responding to the
research questions.
Literature Search Strategy
I used fundamental approaches to search literature outlined by Rothstein (2012)
by using the horizon-scanning and gathering eligible studies. I ensured that relevant
English-language studies published and unpublished were identified by searching the
electronic databases. The search included observational studies and random controlled
trials (RCT) reporting the causes and prevalence of ESBL-PE in LTCFs, and the infection
control measures. PubMed/Medline, Cumulative Index to Nursing and Allied Health
Literature (CINAHL), EMBASE, Google Scholar, and Web of Medicine databases were
searched using the keywords relating to the research topic and questions. I developed the
search strategy for at least two electronic databases mentioned above using the following
terms: extended-spectrum beta-lactamase-producing Enterobacteriaceae or ESBL-PE or
ESBLPE and infection control or infection prevention. Furthermore, the reference lists of
published articles retrieved from these electronic databases were hand-searched for
additional items. The systematic review and meta-analysis of this report adhered to the
Preferred Reporting Items Systematic Reviews and Meta-Analysis (PRISMA) guidelines
to prevent the risk of numerous articles addressing the same research questions, reduce
noses in accumulated publications, and provide transparency in the study (National
Institute for Health Research, 2019). I screened the records based on title and abstract
(First Pass Screening), retrieved through databases against the predefined eligibility
criteria. After that, I screened the full text via Second Pass Screening (SPS) procedures in
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case the information was not clear in the First Pass Screening (FPS) level. As a result of
variation in the terms ‘infection control’ and ‘infection prevention’; ‘extended-spectrum
beta-lactamase-producing Enterobacteriaceae’ and ‘ESBL-PE,’ I make use of those terms
in the search strategies. The reference lists of the journals recovered were also screened
to search for additional literature papers. To address and review these studies, I decided
to include papers that were delineating the etiology of the epidemiology of ESBL-PE,
confirmation of Enterobacteriaceae that produced ESBL enzymes, concerned in
laboratory detection of ESBL-PE, epidemiology of ESBL-PE, and evaluation of infection
control measures in LTCFs globally; demonstration of the potential link
between environmental source, antibiotic use and Enterobacteriaceae resistance in
LTCFs residents; and discussing the importance of the microbiology laboratory
in Enterobacteriaceae resistance to cephalosporins surveillance. The surveillance
included Enterobacteriaceae, how to recognize ESBL producers
among Enterobacteriaceae species, combination disc method, detection of ESBL in Amp
C-inducible species, Control for ESBL confirmatory tests. Generally, I developed a welldefined protocol for commencing the search. Firstly, I breakdown the clinical questions
into the Population, Intervention, Comparison, Outcome, and Study design (PICOS)
format. My research question contains “Infection control of transmitting Beta-Lactamase
producing Enterobacteriaceae (ESBL-PE) among residents and between LTCFs. As
aptly described above, I developed the search strategy for a minimum of two electronic
databases, and I captured the study details, participants detail, intervention details, and
outcome details from the included studies.
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Concern in Laboratory Detection of ESBL-PE
There are β-lactamase family but ESBL consist of large number and most
frequent class of enzymes (Gazin et al., 2012). Detecting ESBL-PE can be challenging
for some reasons, ranging from other enzymes with different features, clinical and
infection control to laboratory concerns. The isolation of ESBL is based upon the
resistance they confer to oxyimino-beta-lactam substrates indicators, such as
cefpodoxime, ceftazidime, ceftriaxone, cefotaxime, or cefepime and the ability of
clavulanate to prevent this resistance. AmpC-type beta-lactamases is a different beta
lactam enzyme features that can be misleading in the laboratory detection of ESBL. This
enzyme can be determined by plasmid and chromosomal genes because of their ability to
provide oxyimino-beta-lactam resistance as well as resisting inhibition by clavulanate.
This AmpC enzyme frequently confer resistance to cephamycins, which ESBL do not.
Difficulties in the detection of ESBL arise because of their heterogeneous in nature. For
example, OXA-type ESBL can be poorly inhibited by clavulanate. Some ESBL are best
isolated with ceftazidime and others with cefotaxime, such as CTX-M enzymes. Infection
control concerns include lack of nursing home infection control protocols that can
recommend active screening. In poor resource settings where infection control measures
are difficult to confirm the presence of suspected ESBL. To implement infection control
protocols for therapeutic purposes and in a timely manner, it is essential that biomedical
scientists in microbiology laboratory can identify ESBL resistance in a timely manner. It
is also essential for regional reference laboratories to confirm the presence of ESBL in
Enterobacteriaceae rapidly (de Kraker et al., 2011). Benchmarks for identifying ESBL
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have changed many times from Clinical and Laboratory Standards Institute (CLSI) to the
European Committee on Antimicrobial Susceptibility Testing (EUCAST) for screening
isolates of ESBL producing Enterobacteriaceae. CLSI has recommended that
Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, and Proteus mirabilis
should be screened by disk diffusion or broth dilution for resistance, which must undergo
confirmatory test in the presence of clavulanate, for increased susceptibility (National
Committee for Clinical Laboratory Standards, 1999). The CLSI published new minimum
inhibitory concentration (MIC) and disk diffusion breakpoints in 2010 for the
Enterobacteriaceae testing (National Committee for Clinical Laboratory Standards,
2010). These MIC breakpoints were adjusted to one to three doubling dilutions which is
lower than the previous breakpoints, and the new disk diffusion criteria. Similarly, the
European Committee on Antimicrobial Susceptibility Testing ([EUCAST], 2010) also
adjusted the breakpoint benchmarks in 2010, for susceptibility testing. To certain degree,
many Enterobacteriaceae that previously would have been classified as susceptible when
used the former breakpoints may now be treated resistant or intermediate (Hombach et
al., 2012). Under these circumstances, the evidence for the new breakpoints may not be
enough (Thomson, 2013) because the test may eliminate the need to perform ESBL
screening and confirmatory tests for Enterobacteriaceae to make treatment decisions, this
treatment could be questionable (Livermore et al., 2012). There are various ways of
conducting ESBL tests, tests can be conducted via automated techniques, such as Vitek 2
(bioMérieux, France) and Phoenix (BD Diagnostics, USA). These devices detect ESBL
with pure culture double disk-synergy confirmation. Other methods also include
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combination disk and double-disk synergy (Moodley et al., 2005). Different antibiotics
were used to identify ESBL activity, though, depending on the ESBL variant. For instant,
cefpodoxime is a secure substrate for the detection of most SHV and TEM ESBL types,
while a combination of cefotaxime and ceftazidime is recommended to detect CTX-M
and some TEM ESBL variant. Yet, a high production of AmpC expression and K1
penicillinases can be identified as false ESBL production due to porin or AmpC βlactamases overexpression (Oliver et al., 2002). For both screening and clinical samples,
a drastic reduction in specificity can occur when evaluating isolates with a high
production of AmpC β-lactamases overexpression (Gazin et al., 2012). Sequencing data
and polymerase chain reaction (PCR)-microarray-based assays can be of essential
requirement in the future for a rapid identification of ESBL in hospital and nursing home
patients at time of their admission (Livermore et al., 2012).
Epidemiology of ESBL-PE
The extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae
(ESBL-PE) have been reported by Centers for Disease Control and Prevention (CDC) and
partners to have increased since 2012 worldwide. The increased of this disease is most
often emanated from the hospital specimens but also in samples from the community.
Prevalence rates may differ from hospital to hospital, from nursing home to residential
care home and from country to country. In the USA, rates of ESBL have reported to be
increased as reflected by a study conducted in South-eastern US hospitals. According to
Thaden et al., 2016, the incidence of ESBL-producing Enterobacteriaceae increased
from 11.1 to 22.1 infections per 100,000 patients between 2009 and 2014. The prevalence
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of ESBL isolates from Asia, Latin America, and the Middle East have also reported to be
higher (Morrissey et al., 2013), extending to a point of 60 percent in Klebsiella
pneumoniae isolates from Argentina and 48 percent in Escherichia coli isolates from
Mexico (Sader et al., 2014; Gales et al., 2012). Karanika et al. (2016) reported how
increment of community-acquired ESBL pathogens led to the detection of high rate of
concomitant and increasing rates of fecal colonization by ESBL-PE worldwide. Risk
factors for infection with ESBL include previous stay in healthcare settings, previous use
of antibiotics, foreign travel (Karanika et al., 2016), immunocompromised, debilitated
and exposure to livestock foods (Liebana et al., 2013). Healthy individuals can also be
infected with ESBL-PE. It is of essential to implement effective control measures to
prevent spread of ESBL diseases when identifying likely carriers of the disease upon
admittance to a healthcare facility. In Lye et al. (2012) study, a prolonged carriage of this
disease for over twelve months was identified, which can create a possible dissemination
of the ESBL-PE between communities, households and possibly nursing home contacts.
The spread of this disease is alarming for public health due to its ability to resist multiple
antibiotic agents, spreading within healthcare systems, infect patients, residents and can
cause outbreaks when transferred patients between healthcare settings (Khun et al.,
2012).
Infection Control
The spread of ESBL-PE between nursing home and hospitals are prevalence,
indicating that breaches in infection control were obvious. The transmission of ESBL-PE
is a public health threat because the infections are associated with multidrug resistance
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organisms (MDROs) and resulted in prolonged hospitalization and high mortality rates
(Pineles et al., 2019). Residents have various risk factors for acquiring infections with
ESBL-PE, these include frequent hospital visits, increased use of antibiotics, functional
impairment, and indwelling devices (Pineles et al., 2019). For the treatment of ESBL-PE
or AmpC producers, carbapenems are the antibiotics of choice, however, the rate at
which carbapenem resistance emerged has also caused a threat to public health
(Rodríguez-Baño et al., 2018). In this situation, the utilization of effective infection
control measures is of significance for this disease. But the difficulties in assessing the
effectiveness of infection control prevention measures on the transmission of ESBL-PE
between nursing home and hospital may force healthcare providers to make use of the
ORION statement. The statement was developed as a guideline for the transparent
reporting of infection control interventions and outbreaks report of health care associated
infection (HCAI) (Stone et al., 2007). Despite guideline that contain infection control
measures, the strategies to prevent the spread of infections ware not specifically available
for ESBL-PE but ware available in guidelines for infection control for other MDROs
(Tacconelli et al., 2014).
Theoretical Foundation
Ecology became a theory currently used by investigators to control human
infectious diseases because the ecologists provided not only datasets for testing
mathematical models developed but also to understand the population dynamics of hostpathogen interactions (Smith et al., 2005). The theory was ddeveloped by psychologist
Urie Bronfenbrenner in 1979, and since that period, ecological theory has been used to
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explain how human development is influenced by different types of environmental
systems (Bronfenbrenner, 2005). As demonstrated by Smith et al. (2005), prevention and
control of the disease have relied upon public health officials who applied knowledge
attained from the work of population ecologists and has resulted in an increasing
understanding that the dynamics of infectious diseases is as ecological as well as a
medical problem. Under those circumstances, the future public policy drives cannot
afford to disregard the results of research on disease-related to ecology. Because of
the essential varieties present in most ecological system, extensive advantages may
be accumulated by identifying and focusing on control and prevention efforts on the
individuals or locations playing an unequal role in the transmission of diseases.
The Ecological Conceptual Framework
It is always demanding to enforce advancement in healthcare settings, especially
residential care homes. However, a growing number of research projects indicated
that there are some reasons why health institutions succeed in this while others failed
(Nilsen, 2015). But the more common procedure is to identify factors that can promote
or delay the successful enforcement of a conceptual framework when using a determinant
framework (Nilsen, 2015). One of these concepts, the ecological conceptual framework
(Durlak & DuPre, 2008), was purposely developed to advance health advocacy and
disease prevention plans' success. This framework's benefit is that it is drawn from
an evidence-based and comprehensive review of relevant literature. From the ecological
framework point, the success of a preventive health program is mostly influenced by
characteristics of the advancement compatibility with existing health quality
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needs, attributes of the long-term care facility providers responsible for
the advancement of self-efficacy and features of the responsiveness of a
broader healthcare system community. The level of support for implementation also
influences this preventative healthcare framework success, for instance, training
healthcare staff and provision of infection control team and also by natures of the
healthcare system within which the concept is implemented, including the general
capability of the care homes to integrate the concept framework innovation of ecological
theory, specific practices and processes (e.g., formulation of tasks), and staffing
considerations relevant to promoting program success (e.g., leadership and supervisory
support). This broad, multi-faceted approach of this conceptual framework ensures
attention to the various levels at which successful infection prevention program
implementation can be compromised or enhanced. Considering the above-mentioned
ecological conceptual framework characteristics, it clearly distinguishes the ecological
concept from other determinant frameworks because of its sensitivity to influence the
socio-political environment in which the ecological theory advancements are
implemented. Because LTC is an institution healthcare setting in which the environment
is known to impact the adoption of knowledge, best practices, and finally the quality of
care (Bowers et al., 2000; Lopez, 2006; Luff et al., 2011; Morgan et al., 2008; Wang et
al., 2005). I regard the ecological framework as robust and relevant to identifying
essential implementation determinants of preventing ESBL-PE in LTCFs environment. I
used the ecological framework to address the following research questions: Is there an
association between LTCF types and the prevalence of ESBL-PE infection rates among
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residents in the presence of other predictors? Is there an association between
environmental sources and the occurrence of ESBL-PE in LTCFs in the presence of other
predictors? What are the essential components of effective infection control in preventing
LTCFs outbreaks?
Literature Review
During ancient Egyptian, Greek, and Chinese medicine, most deaths were
connected to infectious diseases (CDC, 1999), and most of the microbial infections that
caused these contagious diseases were managed and well documented (Sengupta et al.,
2013). In the shortest time, the discovery of narrow-spectrum penicillin by Sir Alexander
Fleming in 1928 changed the face of managing and treatment of infectious diseases that
caused deaths to millions of people in the early 1900s (Piddock, 2012; Sengupta, 2013).
Penicillin was first prescribed in the 1940s to treat infectious diseases among World War
II soldiers, and during this moment, penicillin revolutionized modern medicine that has
had an impact on the lives of millions of people (Frieden 2013; Gould & Bal, 2013;
Sengupta, 2013). Shortly after the discovery of penicillin, the antibiotic resistance
became obvious when Abraham and Chain (1988) reported that Escherichia coli isolates
inactivated penicillin by producing penicillinase enzymes to hydrolyze the beta-lactam
ring of the antibiotic (Spellberg & Gilbert, 2014). In response to this resistance, more
antibiotics were produced to cover these gaps. Unfortunately, many of the bacteria
emerged resistant. In no time, ESBL-PE were identified in Greece in the early 1960s and
further spread to all over the world (Datta & Kontomichalou, 1965). The spread of these
organisms related to increased morbidity and mortality. Under these circumstances, most
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of the beta-lactam empirical antibiotics used for the treatment of infectious diseases were
not effective due to the rise in resistance against antibiotics and resulted in the persistence
and spread of multi-resistant species (Tanwar, 2014: van Duin & Paterson 2016) across
the globe. The resistance represents a severe worldwide risk to public health (Pana &
Zaoutis, 2018). Consequently, despite increased research of these ESBL-PE in hospital
settings, there is a lack of practical studies on Long-Term Care Facilities (LTCFs) in
correlation with ESBL infection rates (Lautenbach et al., 2012). Additionally, most
studies on ESBL infections in both hospital and community settings were often related to
the inappropriate use of antibiotics and patient-level factor, and with this use, this factor
in determining individual risk factors (Lautenbach et al., 2012; Rodríguez-Baño et al.,
2018). In a study conducted by Freedman & Spillman (2014), it was observed that most
care homes were proxy and close living settings with shared toilets among elderly
residents. This could be the most potent correlated source for the risk and cause of the
prevalence of ESBL infection rates. Blom et al. (2016) also pointed out that residential
care settings of different geographical areas could be a risk to the residents in the
acquisition of these infections because it is an environment that is often regarded as a
reservoir for transmitting ESBL organisms between and within residents (High, 2009;
Rooney, 2009). Moreover, the research that Thaden et al. (2016) conducted spotted the
differences in the incidence of ESBL producers and their implications in the community.
For instance, their study indicated that ESBL Klebsiella pneumonia infection remained
stable, whereas community and nosocomial-associated ESBL Escherichia coli infections
are driving the upward trend. All the above methods, the research provided credible and
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logical results, as noted by each assessment. However, there was an indication in
previous studies that the prevalence of ESBL-PE colonization/infection differed
significantly across LTCF sites (Lautenbach et al., 2012). Though there were obvious
reasons for the increasing rate of community associated ESBL infections in public,
private care homes, and tertiary care hospitals (Thaden et al., 2016), the prevalence of
ESBL-PE colonization differed significantly across LTCFs. The differences in the
isolates may be owing to differences in patient demographic populations, lack of
managing antibiotic use, or inconsistence infection control protocols across the
health facilities (Lautenbach et al., 2012). For example, dissemination of ESBL within an
LTCF may be specifically essential in the epidemiology of ESBL-PE. In Lautenbach et
al., 2012 study, the research was apparent that the connection between ESBL-PE
infection and fecal incontinence suggested a possible role for person-to-person
dissemination of the disease. Despite indifference in the underlying mechanisms of
differences in ESBL infection across all the facilities, the implication of this research was
an essential public health concern. Because of the rising rate of ESBL-PE, the first
national Antimicrobial Resistance Action Plan (AMRAP) Northern Ireland was
Launched in 2002 in collaboration with Public Health England (PHE) to curb the threat
of ESBL and prioritized organism for targeted action in controlling infection caused by
ESBL threat in LTCFs and hospital (Public Health Agency, 2015). In summary, the study
aims to assess the prevalence of ESBL-PE among residents in LTCFs and identify
effective infection controls against the disease. This evidence can be used by public and
private residential care homes to develop guidance to be used by health professionals to
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help curb the transmission of ESBL-PE into in LTCFs. Through the systematic review
and meta-analysis, detailing community acquired ESBL-PE, effect, cause, and prevention
were identified. I also briefly discussed surveillance methodologies used in Health and
Social Care (HSC) hospital infection control and prevention programs, particularly the
use of Northern Ireland Electronic Care Record (NIECR) surveillance systems and
infection control teams. The study aims, research questions, and methods were itemized
to pursue the objectives of this dissertation. To prevent a further spread of ESBL-PE
infections in residents by improving infection control and prevention procedures, I
summed up the current knowledge about ESBL-PE in LTCFs. This systematic review
and meta-analyses aimed to assess the analytic epidemiology of ESBL-PE by answering
the following research questions. Is there an association between LTCF and the
prevalence of ESBL-PE infection rates among residents in the presence of other
predictors? Is there an association between environmental sources and ESBL-PE in
LTCFs in the presence of other predictors? What are the essential components of
effective infection control in preventing LTCFs outbreaks?
Summary and Conclusions
Although the study of ESBL-PE prevalence in LTCFs is increased, the higher
percentage of healthy elderly residents, in general, were not affected. Through this
literature review, the data retrieved from different countries showed a shift in the number
of increases in the number of elderly people. With this direction, the elderly residents
requiring adequate care in LTCFs. This review reported that in Northern Ireland, the over
65 years old population is increasing and may outnumber younger people in the
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nearest future (The Executive Office, 2015). At present, there are about 514 nursing
homes and residential care homes in Northern Ireland, approximately two times the
number in 2013 (Public Health Agency, 2013). In 2015, the number of older adults was
15.5% and estimated and projected to increase by 74.4% between 2014 and 2039 (The
Executive Office, 2015). The likely increase in the elderly population can place
significant responsibilities on Northern Ireland's health care and support services. Various
studies have shown a higher prevalence of ESBL species in LTCFs, especially in nursing
homes. This is due to inefficient infection prevention practices, geographical location
differences, proximity among the residents, and excess use of antibiotics (Pelly et al.,
2006). Healthcare professionals have an essential role in controlling the spread of ESBLPE in LTCFs. However, the implementation of targeted infection control protocols based
on evidence-based practices must always be carried out. Importantly, adequate
knowledge of Enterobacteriaceae organism's ability to resist beta-lactam antibiotic in
both the hospital and community are fundamental in the provision of efficient
healthcare. This review also revealed that appropriate training programs aimed at
developing basic skills to provide healthcare staff with the ability to achieve these
targets. These training programs should be used to facilitate any potential defects in
advanced practice to reduce or control the spread of ESBL-PE. The detection of ESBL
organisms could be challenging because of differences among the ESBL- PE and their
ability to spread rapidly among the residents. The antibiotics, such as carbapenems
agents that are still sensitive to ESBL infections, should only be used in acute health
cases to limit or control further spread of ESBL producing species (Rawat & Nair, 2010).
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Chapter 3: Research Method
Introduction
Extended-Spectrum Beta-Lactamase (ESBL) associated resistance microorganism
is a consistent deep public health concern in both the community and hospital settings.
Since the first report of secretion of ESBL by Enterobacteriaceae in 1983 (Knothe et al.,
1983: Navon-Venezia, Kondratyeva & Carattoli, 2017), ESBL has continued to increase
in different level at different healthcare settings and are now a global public health
concern that obstructs the treatment of infections in the community and hospital settings.
The dissemination of ESBL has adverse effects for health service providers, and a variety
of patients have been linked with an unnecessary setback in treatment of these infections
(Kang et al., 2004; Pana, & Zaoutis, 2018) poor outcome (Paterson et al., 2001; Paterson
et al., 2004; Yadav et al., 2015), increases in the long-term stay in hospital (Mangeney et
al., 2000) and high cost of healthcare (Jia et al., 2019; Lautenbach et al., 2001; Lee et al.,
2006). Furthermore, ESBLs are also known to be frequently resisted by multiple
antibiotic agents, including fluoroquinolones and aminoglycosides, therefore reducing the
available antibiotic treatment alternatives. Though ESBLs are traditionally associated
with healthcare settings, more recent reports have shown increasing isolation of these
organisms in the community setting (Abayneh, Tesfaw & Abdissa, 2018). Nursing homes
and other long-term care settings have been suggested as a reservoir for ESBLs in the
community (Arpin et al., 2003; Duval et al., 2019). Most vulnerable residents are
repeatedly at the risk of acquiring ESBL-PE because they were often exposed to
antimicrobials, previous hospital admission, incontinence, urinary catheters, and
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decubitus ulcers (Feneley, Hopley, & Wells, 2015; Nicolle, 2014). In Europe, Cefotaxime
(CTX)-M phenotypic ESBL producing Escherichia coli is the major ESBL strains that
emanated from the community patients as a serious health concern (Valenza et al., 2014;
Woodford et al., 2004), and have been identified with growing resistance rates to other
antibiotic agents (Pana & Zaoutis, 2018). Cefotaxime extended-spectrum beta-lactamase
(CTX-M ESBL) producing Klebsiella pneumonia occurred in 2001 as the first significant
outbreak in the UK. By 2003, exact duplicate and different types of Escherichia
coli CTX-M-15 were distributed in the UK (Isgren et al., 2019; Livermore & Hawkey,
2005). When Rooney et al., 2009 evaluated ESBL strains in Northern Ireland, it showed a
significant level of fecal carriage of Escherichia coli in nursing home residents (Blom et
al., 2016; Rooney et al., 2009). In a weekly health protection report in England, Wales,
and Northern Ireland, the report showed that Enterobacteriaceae associated ESBLs strain
in these regions were frequently conveyed resistance to multiple antibiotic agents (Public
Health England, 2017). The ESBL producing Escherichia coli has been thought to
convey this multiple resistance to all the antibiotics, especially fluoroquinolones and
gentamicin (Fair & Tor, 2014), and were associated with a long-term care facilities
outbreak (Pelly et al., 2006). The study is significant and insightful because
Enterobacteriaceae that convey resistance to third-generation cephalosporin with nonESBL strains were evaluated and accounted for why the isolates are prevalent among
residents in nursing homes in Northern Ireland and are of public health concern (Public
Health Agency, 2019). In as much as ESBL-PE has limited treatment options, the disease
could endanger a more significant number of patients and residents (Weiner, 2016). The
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changing description of the prevalence in ESBLs producing Enterobacteriaceae has more
tendency to convey resistance to non-beta-lactam antibiotics and vice versa. However,
similar observations have been researched in a study conducted by Procop et al. (2003)
and Teklu et al. (20190). They need to compare the frequency of resistance of these
organisms for five years in Northern Ireland. The outcome of this research could be used
to clarify the magnitude of dissemination of these organisms. It should inform healthcare
service providers and public health awareness of this growing problem. The research
provided the variation of the Enterobacteriaceae species with ESBL enzymes among
residents of nursing homes in Health and Social Care (HSC) locations in most parts of the
world. Notably, the study also provided a significant understanding of ESBL-PE
resistance patterns and informing public health, infection control, and antimicrobial
stewardship approaches to check the dissemination of the emerging pathogens. This
dissertation aimed to provide the first comprehensive systematic review and metaanalysis of ten-year associated risk factors, incidence risks, and the occurrence of ESBLPE infections among residents in LTCFs. The research was explored better through
the research questions.
Purpose of the Study
Long-term care facilities serve a different type of healthcare setting that cares for
individuals of all ages and provides a certain level of care services. The facility homes
also serve as home and health institutions for most older adults and individuals with
intellectual disabilities (Johansson et al., 2017). Despite these facilities' caring nature, the
facilities also provided a unique setting for sharing multidrug resistance organisms
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(MDROs), such as ESBL-PE infections within residents and between health care
facilities via workers who work in more than two care homes (Curran, 2017). These
organisms can curse urinary tract infections and severe infections in the bloodstream and
central nervous system. Numerous journals have researched these MDROs with different
methods of controlling diseases without much success. The purpose of this study was to
use systematic review and meta-analysis to identify, evaluate, and compile the findings of
all relevant individual studies on the causes of the prevalence and control of ESBL-PE in
LTCFs and the evidence for the effectiveness of infection control and prevention
strategies. The intervention measures aim to prevent and control the spread of ESBL-PE
in elderly care homes, especially when residents are in a debilitating health condition or
transferred from the hospital. The examination of ESBL-PE outbreak within elderly
resident homes permitted this research to present the evidence about the role of targeted
or non-targeted infection control interventions, which includes screening tests in the
etiology of ESBL enzymes in LTCFs. The study identified the effective control measures
applied against ESBL-PE prevalence in LTCFs of previous research. I developed the
search strategy for the publications from 2008 to 2018 from at least two electronic
databases like PubMed/Medline, Embase, and Cochrane by using the following terms:
extended-spectrum beta-lactamase-producing Enterobacteriaceae long term care
facilities or ESBL-PE long term care facilities or ESBL-PE long term care facilities and
infection control long term care facilities or infection prevention long term care
facilities. I screened the search records based on title and abstract through a screen called
First Pass Screening (FPS), retrieved through databases against the predefined eligibility
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criteria. The quality assessment used on study design included non-Randomized
controlled trials; I used the New Castle Ottawa Scale (NCOS) for an observational study.
I used statistical software program called RevMan sourced from Cochrane to perform
statistical analyses of the research. The meta-analysis of categorical data was analyzed,
and pooled the estimates, and presented as Risk Ratio (RRs) and analysis of continuous
data was analyzed, and pooled the assessments, and presented as Mean Difference (MD)
along with their 95% confidence intervals (CIs). I also performed a subgroup
analysis based on gender, region, etc., to find the heterogeneity.
Research Design and Rationale
The study is designed as a systematic review and meta-analysis of published and
unpublished articles from January 2008 to December 2018 to investigate the causes of the
prevalence and control measures of ESBL-PE in LTCFs. The study will be investigated
in Northern Ireland, United Kingdom. In Northern Ireland, there are roughly 1.8 million
population with 43,844 nursing homes places available (263 nursing homes) and 19,832
residential care available between January 2014 and December 2018 respectively (251
residential care homes) (Northern Ireland Information Statistics and Research Agency,
2019). I retrieved secondary data for the study population from public databases like
PubMed/Medline, Embase, Google scholar, and Walden library. The demographic data
regarding LTCFs were obtained from the databases mentioned above. Inclusion and
exclusion criteria will be used to determine journal articles to be included in the study.
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Methodology
Target Population
The target populations that I intend to investigate are the resident’s data living in
different types of LTCFs. The data were retrieved from the public databases mentioned
under the research design and rationale. These target populations were investigated based
on their different level of environmental independent variables that could cause risk to
the occurrence of Enterobacteriaceae that produce ESBL enzymes. The relationship
between these risk factors and the occurrence of ESBL infections within and between the
LTCFs were examined to determine variables that are correlate with these organisms.
The difference occurrence of these organisms between residents living in the LTCFs was
analyzed.
Estimated Size of Target Population and Sample
LTCFs are a different type of healthcare settings that serve residents of all ages
and provide variable degrees of care. These facilities serve as a home as well as a place of
caring for residents (Department of Health, Social Service Northern Ireland, 2015). The
facilities are also a special environment for transmitting infections between and within
residents (High, 2009; Rooney, 2009). In the past 40 years, the Northern Ireland
population of over 65 years old is increasing and may outnumber younger people in
nearest future (The Executive Office, 2015). At present, there are about 514 nursing
homes and residential care homes in Northern Ireland (Northern Ireland regulation and
quality improvement authority,2019), approximately two times the number in 2013
(Public Health Agency, 2013). In 2015, the older adults were 15.5% and had been
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estimated and projected to increase by 74.4% between 2014 and 2039 (The Executive
Office, 2015). The likely increase in the elderly population can place significant
responsibilities on Northern Ireland health care and support services. One of the
objectives of this study is to attain a statistical power of at least 0.95 of detecting the
relationship between LTCFs and ESBL infection rates, and in detecting the relationship
between geographical locations (environmental sources) and ESBL infection rates. A
commonly used interpretation based on benchmarks suggested by Cohen (1988) was used
as power analysis for meta-analytical procedures of this research where (d = 0.2)
represents the small size, (d = 0.5) medium, and (d = 0.8) large. Sample sizes in this
research are small. I expected the average group size to be 20. I expected to find ten
studies to be frequent in this research. And my anticipation was to achieve moderate
heterogeneity as = .50. In the end, the sample size that I included for meta-analytical
research was N = 22. In the supplementary statistics, the G*Power 3.1.9.4 was used to
conduct the power analysis. The G*Power calculation for a multiple linear regression
with three predictors and an effect size of R-square (f2) = 0.467. In the context of multiple
regression power analysis, two layers of tests needed to consider—the R-square value test
already tested to be a value of = 0.467 (Table 4). By using G*Power, we needed to
include. the projected - alpha level for the test = 0.05, The Number of predictors in the
regression model was 3, the desired level of power for the test was 0.95. Estimated
population effect size (R2) = 0.467 (Table 4). Under this condition, the expected sample
size was 36 after the G*Power calculation with all the requirements mentioned above.
Already, the included sample size for this research was N = 22. All data analyses were
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listed with hypotheses. Table 1 contained a list of the variables and the statistical tests
were used in each hypothesis.
Table 1
Variables for the LTCFs Study and Elderly Residents’ Study
Types of variable

Variables

Measurement

Dependent variables

ESBL producing Enterobacteriaceae Infections

Interval

Independent variables Types of LTCFs

Categorical

Independent variables Geographical location of LTCFs

Interval

Independent variables infection control measures

interval

Hypothesis 1
H01: There is no association between LTCF and ESBL-PE infections in the
presence of predictors.
Ha1: There is a significant association between LTCF and ESBL-PE infections in
the presence of other predictors.
According to Northern Ireland Regulation and Quality Improvement Authority
(NIRQIA) (2019), there is a collection of LTCF types. The regulation recognized nursing
homes, residential care homes, domiciliary care, mental health, and learning disability
service. In this study, LTCFs were considered for systematic review and meta-analysis
study. I used the hypothesis to conduct effect of LTCF on ESBL-PE infection rates in the
presence of other predictors. LTCF is a categorical variable. Meta-analysis and
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multivariate linear regression (MLR) were conducted to determine if LTCF was
associated with ESBL infection.
Hypothesis 2
H02: There is no association between geographical locations (environmental
sources) and ESBL-PE infections in the presence of predictors.
Ha2: There is a significant association between geographical locations
(environmental sources) and ESBL-PE infections in the presence of other predictors.
Included data retrieved from different countries via databases provided statistical
information relating to the geographical location of LTCFs. The geographical location of
Long-term care facilities is an interval measurement. The LTCFs environment were
evaluated in the presence of other environmental factors to determine if there was
significant association to ESBL-PE infection rates. Meta-analysis and MLR were used to
conduct relationship between the geographical location of LTCFs and ESBL-PE infection
in the presence of the other environmental variables.
Hypothesis 3
H03: There is no association between infection control measures and ESBL-PE
infections in the presence of predictors.
Ha3: There is a significant association between infection control measures and
ESBL-PE infections in the presence of other predictors.
Sampling and Sampling Procedures
According to National Health Service (NHS), samples collection criteria, clinical
samples must be collected in line with the appropriate microbiology departmental
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procedure, laboratory handbook information, ward protocol or LTCFs procedure for the
test required. The prompt and accurate isolation of infecting bacteria is directly
influenced by the quality of the specimen. Consequently, more clinical details of each
patient aid laboratory testing. The NHS laboratory handbook information states that
except for suspected meningitis it is recommended that appropriate specimens should be
collected before commencing antibiotic therapy; specimen should be transported to the
laboratory as soon as possible; ensure that the specimen container is clearly labelled with
the patient’s details, and we should remember that we may be dealing with pathogenic
microorganisms and care should be taken while obtaining and handling the specimen.
Inclusion and Exclusion Criteria
Papers were included if they reported residents, irrespective of gender, age,
ethnicity, and were exposed to cases of ESBL-PE introduced by LTCFs transfer. Papers
excluded if they reported residents were not exposed to cases of ESBL-PE introduced by
LTCFs. Data that contain targeted or non-targeted infection control interventions
included screening tests as well as standard precautions or placebo screening. All the
information were included in this study. Studies that reported transmission or spread of
ESBL-PE within residents in LTCFs causing incidence or frequency of infection,
mortality rate, including length of residents in care homes and resources used were
included. Studies which did not report data on acquisition outcomes were excluded. The
study design was not limited regarding study type, that is, randomized controlled trials
(RCTs) and observational studies. Publications which are published from 2008 to 2018
were included. Publications which are published before 2008 and after 2018 were
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excluded. Research studies related to nonhuman infections, nonhealthcare-related studies,
conference abstracts, letters to the editor, commentaries, weekly reports, and editorials
were excluded also. Only articles written in English included.
Review Descriptions
There are three main relationships for this review, to show awareness of ESBLPE transmitting between hospitals and nursing homes while transferring or moving
patients between the two healthcare settings, and the effective infection control measures
applied. A study was defined based on published papers retrieved from databases with the
only distinction being ‘ESBL-PE’, ‘LTCFs’, and ‘infection control measures.’ So, if a
single paper meeting the selection criteria reported data on the three subjects, they
included three separate studies. Community-acquired infection (CAI) was defined as
infections contracted outside of a hospital. These infections can be obtained from nursing
homes, elderly residential care facilities, or outpatient clinics that require hospitalization.
A number of these infections are caused by gram-negative bacteria (GNB), most
especially Enterobacteriaceae species (Grosso et al., 2015). A hospital-acquired infection
(HAI) was defined as infections acquired in a hospital. The infections often contacted
after 48 hours of hospital admission or within 48 hours of hospital discharge (Peleg &
Hooper, 2010). Infection control measures ware defined as standard precautions to reduce
the risk of transmitting bacteria diseases from both recognized and unrecognized sources
(World Health Organization, 2006). Residents in a nursing home are often transferred to
an Accident and Emergency Department (AED) when they need urgent, intense medical
care. A proportion of these transfers often performed on an outpatient basis and may be
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considered inappropriate due to the lack of effective infection control measures
(Lemoyne et al., 2019). This review is considered the CAI and HAI as a wider definition
of healthcare-associated infections (HCAIs). The HCAIs can occur when patients are
receiving health care and probably contracted the disease in a hospital or nursing home
that first appears after 48 hours (Haque et al., 2018).
Determination of Study Selection
The relevant published and unpublished articles and the processed results were
selected based on the following analysis criteria: year of publication, keywords, the
relevance of the article, type of publications, study design, and language of the
publications. The designating period of the study was used as the first criterion. The key
words reflected the terminology were employed in the selected articles and helped in
identifying the most relevant studies. Each abstract publication was thoroughly checked
and rejected any irrelevant studies. Original and reviewed studies was selected, but some
papers required the use of information from annual reports, research reports, or
conference reports, all these were also be utilized. The study design was divided into
reviews versus original works or, with cross-sectional versus longitudinal. The eligible
literature papers were assessed for quality and risk of bias for data that were relevant to
the systematic review and meta-analysis. The languages that currently predominate in
science are English and Spanish (Čablová et al., 2017), but in this review, only the
English language was used for the study. The differences in either the application of
inclusion or exclusion of articles, quality accuracy on data extraction were evaluated to
make the final decision.
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Data Extraction Process
Data were extracted from the inclusive eligible papers and reviewed were carried
out on the studies. Papers extracted have been scrutinized, double-checked for eligible
criteria, and variables were assessed and evaluated for processing. The data extracted
from acceptable studies consist of; Author and year of publication, study aim, the country
where the study was conducted, study design, infection control measures, strains of
ESBL-PE detected, number of Patients, Interventions, age, and sex distribution. I ensured
that data were extracted and analyzed twice to remove any lack of consistency.
Risk of Bias in each of Studies
Modified version of the Newcastle-Ottawa Scale (NOS) is a risk of bias appraisal
tool for studies supported by the Cochrane Collaboration (Higgins & Green, 2011; Wells
et al. 2014). The content validity of this tool has been established based on a critical
review studies across different researchers in the field who evaluated its clarity for
critical review of appraising the quality of studies to be used in a meta-analysis (Wells et
al., 2014). The NOS is used to assess the quality and risk of bias of the papers included in
this review. Using NOS quality assessment tool to appraise this review critically, the
included studies were evaluated based on Cochrane ‘Risk of bias’s assessment of ‘Low
risk’ of bias, ‘High risk’ of bias, or ‘Unclear risk’ of bias according to published
criteria (Higgins & Green, 2011).
Data Analysis
The combined proportions of patients admitted into the LTCFs or moved to the
nursing home (with 95% confidence intervals), with or without pre-arranged infection

55
control measures, with patients at risk of ESBL-PE infection was calculated separately
and compared between possible transmission of ESBL-PE among residents in LTCFs,
and infection control applied using a random-effects meta-analysis model based on
DerSimonian-Laird approach (Cooper et al., 2009; DerSimonian & Laird, 1986). With
this approach, I estimated the mean of a distribution of effects in a different population.
This approach includes an estimate within-studies and between-studies variation, which
was used when assigned the studies into weights and the standard error of each effect
size. The precision of an estimated random effect's analysis from each study is weighted
by the inverse of the results' variance across all the pooled studies. If the studies'
value were within the 95% CI, then the effect size would be statistically significant at the
5% level (P<0.05). Though the chi-square test provided a test of significance for
heterogeneity without measured it, these studies' heterogeneity nature was evaluated by
using the I2 statistic with a P-value of <0.05 considered to be statistically significant. The
I2 values represented the percentage of the total variation which was due to the variation
between studies. According to Higgins et al. (2003), I2 suggested that: I2 = 0% is no
heterogeneity, I2 = 25% and below is low heterogeneity, I2 = 50% is moderate
heterogeneity, and I2 = 75% is high heterogeneity. This measurement is used to define the
level and presence of the index of heterogeneity in a meta-analysis. Study between-study
heterogeneity make the effect size estimate less accurate because of slight differences in
the study design or intervention components between the studies. Many other differences
in the study population are possible and may also be associated with differences in the
overall effect. In this case, I used subgroup analyses to examine different subgroups
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within our meta-analysis articles to determine the differences of effect in a subset of
subject's risk of bias, study duration, age group, ESBL-PE transmission cause, and
Infection control measure. I calculated the Standard Error of the differences between
subgroup effect sizes to calculate confidence intervals and compared the size of each
subgroup's effects to know if this difference is significant (Borenstein et al., 2011). Also,
I did not used meta-regression to examine if covariates explained any of the
heterogeneity of infection control effects between studies because in meta-analysis, I
need an appropriate larger number of studies to covariates (Borenstein et al., 2011).
However, it is not reasonable to deduce that all the heterogeneity should be elucidated
because the residual heterogeneity is expected to be recognized in the statistical analysis
(Loannidis, 2008). In such a manner, it is impractical to assess these covariates in each
study. And without doubt, I may not know the association of covariates with the size of
the effect. However, Borenstein, Hedges & Rothstein, 2007, admitted that the association
of the effect's size with covariates did exist but may lead to variations in a high degree of
effect. According to Rothstein, Sutton, & Borenstein, 2006, the publication bias problem
is a study with high effect sizes that are more likely to be published than a study with a
small effect size. I used a funnel plot to estimate the assessment of publication bias.
Furthermore, I analysed pooled proportions of residents in LTCFs over time using the
study year. For studies taking place in 2 years, I used the first year; for studies taking
place in 4 years, I used the second year; for those studies in six years, I used the third
year. The non-parametric Spearman's rho correlation coefficient was calculated to
determine significance in ESBL-PE transmission among residents and between LTCFs
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trend over time. Statistical analyses were undertaken using Cochrane RevMan statistical
software.
Summary of Design and Data Analysis Plan
Generally, I developed a well-defined protocol before commencing the systematic
review and meta-analysis.
Step 1: Firstly, I breakdown the clinical question into PICOS (Population,
Intervention, Comparison, Outcome, and Study design) format. My research question
contains “Infection control of transmitting or prevalence of ESBL-PE among residents in
LTCFs”.
•

P (Population) included residents who were exposed to cases of ESBL-PE
introduced by LTCFs environment. Residents Irrespective of gender, age, and
ethnicity were included. Residents who were not exposed to cases of ESBL-PE
introduced by LTCFs environment were excluded.

•

I (Intervention) included targeted or non-targeted infection control interventions
which includes screening tests.

•

C (Comparator) included standard precautions or placebo screening.

•

O (Outcome) included transmission or spread of ESBL-PE within residents in
LTCFs and between facilities: incidence or frequency of infection, Mortality rate,
and resources used. Studies with no report data on acquisition outcomes were
excluded.

•

S (Study design) I included data with limit to study type (Randomized controlled
trials (RCTs) and observational studies).
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•

T (Time period) I included publications published from 2008 to 2018 and
publications before 2008 and after 2018 were excluded.
Step 2: I developed the search strategy for at least two electronic databases like

PubMed/Medline, Embase, Google Scholar and Cochrane by using following terms:
extended spectrum beta lactamase producing Enterobacteriaceae or ESBL-PE or
ESBLPE and infection control or infection prevention.
Step 3: Screening the records based on title and abstract via First Pass Screening
(FPS) which are retrieved through databases against the predefined eligibility criteria.
After that I did the full-text screening via Second Pass Screening (SPS) if the information
is not clear in the FPS level.
Step 4: I captured study details, participants detail, intervention details, and
outcome details from the included studies.
Step 5: Quality assessment based on study design of included studies were
examined. I used the Risk of Bias tool for RCTs and the New Castle Ottawa scale for
observational study.
Step 6: Statistical analyses were performed using ‘Cochrane RevMan statistical
software’. A The meta- analysis of categorical data was analyzed, and pooled the
estimates, and presented as Risk Ratio (RRs). Also, the analysis of continuous data was
analyzed, and pooled the estimates, and presented as Mean Difference (MD) along with
their 95% confidence intervals (CIs).
Step 7: Subgroup analysis was performed to find the heterogeneity.
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Step 8: Publication bias was performed if 10 studies are there for at least one
outcome.
The purpose of the design and data analysis summary was to create a plan for the
meta-analysis study in next chapter. The concepts in this section were used to summarize
study data and to process the relevant statistical tests.
Threats to Validity
Bias in each of the Studies and random error could threaten this research's validity
if I did not put adequate strategies to limit them. These strategies include a complete
search for relevant articles and explicit, reproducible criteria in the selection of articles
included in the review. The study is a systematic quantitative review that summarized the
results of the published and unpublished studies and used statistical methods to sum up
the results of the different tasks into a single pooled estimate of effect. I have appraised
the research designs and study characteristics, synthesized the data, and interpreted the
results using a predefined systematic approach to conform to evidence-based
methodological principles. The guidance below is organized and employed to limit the
threats of the validity of this research. Data were extracted from the inclusive eligible
papers and reviewed were carried out on the studies. Papers selected have been
scrutinized, double-checked for eligible criteria, and variables were assessed and
evaluated for processing. The data extracted from acceptable studies consist of; Author
and year of publication, study aim, the country where the research was conducted, study
design, infection control measures, strains of ESBL-PE detected, number of Patients,
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Interventions, age, and sex distribution. I ensured that data were extracted and analysed
twice to remove any lack of consistency.
Included and excluded Studies: I selected the relevant published and unpublished
articles and the processed results based on the following analysis criteria: year of
publication, keywords, the relevance of the article, type of publications, study design, and
publications' language. The designating period of the study was used as the first criterion.
The keywords reflected the terminology was employed in the selected articles and helped
identify the most relevant studies. Each abstract publication was thoroughly checked and
rejected any irrelevant studies. Original and reviewed studies were selected, but some
papers required information from annual reports, research reports, or conference reports;
all these were also be utilized. The study design was divided into reviews versus original
works or, with cross-sectional versus longitudinal. Assessment of Risk of Bias in each of
Studies: A modified version of the Newcastle-Ottawa Scale (NOS) is a risk of bias
appraisal tool for studies supported by the Cochrane Collaboration (Higgins & Green,
2011; Wells et al., 2014). This tool's content validity has been established based on
critical review studies across different researchers in the field who evaluated its clarity
for critical review of appraising the quality of studies used in a meta-analysis (Wells et
al., 2014). The eligible literature papers were assessed for quality and risk of bias for data
relevant to the systematic review and meta-analysis. The NOS is used to evaluate the
quality and risk of bias of the papers included in this review. Using NOS quality
assessment tool to appraise this review critically, the included studies were evaluated
based on Cochrane' Risk of bias's assessment of 'Low risk' of bias, 'High risk' of bias, or
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'Unclear risk' of bias according to published criteria (Higgins & Green, 2011). The
languages currently predominate in science are English and Spanish (Čablová et al.,
2017), but I only used the English language for the study in this review. I evaluated the
differences between the inclusion or exclusion of articles and quality accuracy on data
extraction to make the final decision. To further minimize the potential for bias in each
publication, I conducted a complete literature search to include the strategies discussed in
Question 3. I used a graphical funnel plot of studies in a meta-analysis for identifying
bias in each study.
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Chapter 4: Results
Introduction
The purpose of this quantitative systematic review and meta-analysis was to
gather all available empirical research about the causes of prevalence and control
measures of ESBL-PE among residents in LTCFs by using clearly defined, systematic
approaches to achieve answers to the following research questions.
Research Question 1: Is there an association between LTCF and the prevalence of
ESBL-PE infection rates among residents in the presence of other predictors?
H01: There is no association between LTCF and ESBL-PE infections in the
presence of predictors.
Ha1: There is a significant association between LTCF and ESBL-PE infections in
the presence of other predictors.
Research Question 2: Is there an association between geographical (environmental
sources) and ESBL-PE in LTCFs in the presence of other predictors?
H02: There is no association between environmental sources and ESBL-PE
infections in the presence of predictors.
Ha2: There is a significant association between environmental sources and ESBLPE infections in the presence of other predictors.
Research Question 3: Is there an association between Infection Control Measures
and ESBL-PE infections?
H03: There is no association between infection control measures and ESBL-PE
infections in the presence of predictors.
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Ha3: There is a significant association between infection control measure and
ESBL-PE infections in the presence of other predictors.
These hypotheses have been tested through the meta-analysis of continuous data, pooled
the estimates, and presented as mean difference (MD) along with their 95% confidence
intervals (CIs). The analysis process was based upon the data analysis plan as stated in
Chapter 3.
Data Collection
Data collection is one of the essential stages in conducting a meta-analysis. The
data collection method was the evidence used to describe in detail the analysis of
prevalence and control measures of ESBL-PE in LTCFs. The data provided in this project
served as information to determine if the studies that were included were suitable for a
combined analysis. I developed the search strategy using electronic databases
PubMed/Medline, Embase, Cochrane and Google Scholar by using following terms:
extended spectrum beta lactamase producing Enterobacteriaceae OR ESBL-PE or
ESBLPE AND infection control OR infection prevention. I collected data such as
information on transmission or spread of ESBL-PE within residents (participants) in
LTCFs: incidence or frequency of infection, mortality rate, length of care homes stays,
and resources used. Where applicable, information on control measures were also
collected, these includes general control measures, standard precautions, active
surveillance, environmental control, prophylaxis based on the World Health Organization
(WHO), hand hygiene, training and educating HCWs employee, and containment
measures. After the collection of all information, through the First Pass Screening (FPS),
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I screened the records based on title and abstract which are retrieved through databases
against the predefined eligibility criteria. In case the information was not clear in the FPS
level, I conducted the full-text screening called Second Pass Screening (SPS). At this
stage, the study details, participants detail, intervention details, and outcome details from
the included studies were captured. Quality assessment based on study design of included
studies was evaluated using New Castle Ottawa scale (NOS), a risk of bias assessment
tool for observational study. Statistical analyses were performed using the ‘‘Cochrane
RevMan’’ statistical software program. The meta-analysis of categorical data was
analyzed, and pooled the estimates, using inverse variance statistical method with random
effects (RE) analysis model and analysis of continuous data, and presented as mean
difference (MD) along with their 95% confidence intervals (CIs). I also performed a
subgroup analysis based on ESBL prevalence on geographical (regions), targeted and
untargeted infection control measures, to find the heterogeneity.
Data Analysis
The combined proportions of residents in LTCFs (with 95% confidence intervals),
with or without ESBL-PE infection were calculated and compared, using a randomeffects meta-analysis model based on DerSimonian-Laird approach (Cooper et al., 2009;
DerSimonian & Laird, 1986). With this approach, I estimated the mean of a distribution
of effects in a different population. This approach includes an estimate within-studies and
between-studies variation, which were used when assigned the studies into weights and
the standard error of each effect size. The precision of an estimate random effect's
analysis from each study was weighted by the inverse of the variance of the results across
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all the pooled studies. The studies' value was within the 95% CI, then the effect
size would be statistically significant at the 5% level (P < 0.05). Though the chi-square
test provided a test of significance for heterogeneity without measured it, the
heterogeneity nature of these studies was evaluated by using the I2 statistic with a P value
of <0.05 considered to be statistically significant. The I2 values represented the
percentage of the total variation which was due to variation between studies. According
to Higgins et al. (2003), I2 suggested that: I2 = 0% is no heterogeneity, I2 = 25% and
below is low heterogeneity, I2 = 50% is moderate heterogeneity, and I2 = 75% and above
is high heterogeneity. This measurement was used to define the level and presence of
index of heterogeneity in meta-analysis. However, if the study between study
heterogeneity turned the effect size estimate to be less accurate, this could be as a result
of slight differences in the study design or intervention components between the studies.
Many other differences in the study population are possible and may also be associated
with differences in the overall effect. In this case, I used subgroup analyses to examine
different subgroups within the articles of our meta-analysis to determine the differences
of effect in subset of subject’s risk of bias, study duration, regional areas of ESBLs PE
transmission cause, and Infection control measure. I calculated the Standard error of the
differences between subgroup effect sizes, to calculate confidence intervals and
compared the size of the effects of each subgroup to know if this difference is significant
(Borenstein et al. 2011). Also, I did not used meta-regression to examine if covariates
explained any of the heterogeneity of infection control effects between studies because in
meta-analysis, I need an appropriate larger number of studies to covariates (Borenstein et
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al., 2011). However, this was not reasonable to deduce that all the heterogeneity should be
elucidated because the residual heterogeneity is expected to be recognized in the
statistical analysis (Loannidis, 2008). In such manner, it was impractical to assess these
covariates in each study, and I did not know the association of covariates with the size of
the effect. However, Borenstein et al. (2007) admitted that the association of the size of
the effect with covariates did exist but may lead to variations in a high degree of
effect. Publication bias problem, according to Rothstein et al. (2006), was a study with
high effect sizes that more likely to be published than a study with a low effect size. I
used a funnel plot to estimate the assessment of publication bias. Statistical analyses were
undertaken using ‘‘Cochrane RevMan’’ statistical software program.
Results Study Selection
I searched electronic database and able to identify 3,106 potential studies and 8
additional records were identified via hand searching. After 2878 irrelevant titles and
duplicates removed, 236 articles remained to be screened for title and abstract. I
evaluated 63 as potentially eligible full-text articles to be retrieved. After the application
of inclusion and exclusion criteria, 22 articles (35%) considered to have information
admissible to this systematic review and meta-analysis. These 22 articles include five risk
factors associated with faecal carriage of ESBL-PE studies and seventeen prevalence of
ESBL-PE in LTCFs studies. The PRISMA flow chart describing the papers identified
from the search strategy and reasons for exclusion is shown in Figure 1.
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Figure 1
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database searching
(n = 3,106)

Additional records identified via
hand searching (n = 8)

2878 irrelevant titles & duplicates
removed
(n = )

236 Records screened.

63 Full-text articles
assessed for eligibility.
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22 articles selected for
the analysis.

8 duplicates
4 reports on ESBL,
3 Letters to Editor
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6 Reviews

Studies included in
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(meta-analysis)
(n = 22)

8 cannot access.
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Study Characteristics
Geographically, 15 of the 22 studies were carried out in Europe (68.1%; n=15),
Asia (18.2%; n=4), North America (9.1%; n=2) and Australia (4.5%; n=1). In this
analysis, there were two (9.1%) ESBL-PE in LTCFs studies conducted in developing
countries and 20 (91%) studies conducted in developed countries. Most of the studies
(40.9%; n=9) followed a cross sectional design. Other studies followed point prevalence
study (27.2%; n=6) and screening (18.2%; n=4) respectively, while each study including
observational cohort, nested case-control study and retrospective were (4.5%; n=1)
respectively. The duration of studies ranged from 0 to 107 months. The study populations
of the studies included residents of both sexes. Appendix A provides further details on
the characteristics of the included studies.
Figure 2
Forest Plot of Included Studies

Note. Observed infection rates between ESBL-PE and non-ESBL-PE in all studies, effect
size (ES) and confidence interval (CI). ‘‘Cochrane RevMan’’ statistical software
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program. Figure 2 shows the forest plots of included studies reporting on ESBL-PE and
non-ESBL-PE infections. The 22 studies from 2008 to 2018 were published in the
English language. Fifteen studies were conducted in Europe, four studies were conducted
in Asia, two studies were performed in North America, and one study was performed in
Australia. The pooled prevalence of ESBL-PE infections among LTCF residents was
15.78 (95% CI 0.04 – 31.53). Heterogeneity is confirmed by a high l2 value of = 100%
and a significantly associated p-value (<0.00001). In the light of such a large significant
heterogeneity, caution is justified in explaining the summary estimate (diamond shape).
The I2 values represented the percentage of the total variation, which was due to variation
between studies. According to Higgins et al. (2003), l2 suggested that: l2 = 0% is no
heterogeneity, l2 = 25% and below is low heterogeneity, l2 = 50% is moderate
heterogeneity, and l2 = 75% and above is high heterogeneity. I used heterogeneity
measurement to define the level and presence of the index of heterogeneity in this study.
The outcome effect measure for Enterobacteriaceae infection is expressed as a mean
difference. The vertical line at 0 interpreted to be no difference in
Enterobacteriaceae infection scores in ESBL-PE infection and non-ESBL-PE infection.
Observation at the pooled effect estimate, the black diamond was almost crossed the
vertical line (mean difference: 15.78, 95% CI: 0.04, 31.53), and thus showing a
statistically significant effect favoring ESBL-PE infection. The overall effect test
corroborates the results by presenting a p- equal 0.05 (p = 0.05).
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Figure 3
Scatter funnel plot of Enterobacteriaceae among residents in LTCFs included studies
year of study (1998-2012)

Note. Source: ‘‘Cochrane RevMan’’ statistical software program.
Regional Forest Plots
Forest plot of studies reporting on ESBL and non-ESBL-PE infection in the
LTCFs by geographical locations (continents): Europe (68.1%; n=15), Asia (18.2%;
n=4), others North America (9.1%; n=2) and Australia (4.5%; n=1), respectively.
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Figure 4
Forest Plot by Europe Region

Note. Source: Comprehensive meta-analysis software

Figure 5
Forest Plot by Asian Region

Note. Source: ‘‘Cochrane RevMan’’ statistical software program.
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Figure 6
Forest Plot by Other Regions (North America and Australia)

Note. Source: ‘‘Cochrane RevMan’’ statistical software program.
The above regional forest plot studies have been conducted in different
countries, in other contexts (for instance, in nursing or residential homes managed
by government and non-governmental organizations) with residents from different
genders, ages, and various social backgrounds. The outcome effect measure
for Enterobacteriaceae infection in each regional forest plot is expressed as a standard
mean difference. The vertical line at 0 was interpreted to be no difference
in Enterobacteriaceae infection scores between ESBL-PE and non-ESBL-PE infections
in each region. Comparison observation at the pooled effect estimate between the areas,
the black diamond was barely crossed the vertical line 0.61 (95% CI: 0.32, 0.91) in the
Europe region but crossed the vertical line 14.92 (95% CI: 9.17, 20.58) in Asia region,
and the diamond was at the center, that is, there is no apparent difference 0.51(95% CI:
0.36, 0.67) between the intervention group and the control group in other regions (North
America and Australia). The standard mean difference of the regional infection was thus
showing a statistically significant effect favoring prevalence of ESBL-PE infection in
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each of the regions (<0.0001), and the test for the overall effect of these regions have
corroborated the results by presenting a p-value <0.05 (p = <0.0001). These show a
significant association between each environmental/regional source and prevalence of
ESBL-PE in LTCFs.
Figure 7
Forest plot of included studies reporting on Enterobacteriaceae infection in the LTCFs
by infection control measures, effect size (ES) and confidence interval (CI)

Note. Source: ‘‘Cochrane RevMan’’ statistical software program.
In the analysis of pooled ESBL and non-ESBL-PE prevalence, infection control measures
were reported and implemented in nine of twenty-two studies with 13.59 (95% CI: 5.32 –
21.86). The level and presence of the index of heterogeneity in this study is I2 = 99%.
There was considerable heterogeneity among the LTCFs studies (9 = 99%, P<0.0001),
this means that the meta-analytic effect is statistically significant. The meta-analysis aims
to test the hypothesis that there is a significant association between targeted infection
control measures and ESBL-PE infections, then the null hypothesis can be rejected, and
the alternative hypothesis (that there is an effect) is deemed more likely in this study. The
observed pooled effect estimate showed the black diamond that crossed the vertical line
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(mean difference: 13.59 (95% CI: 5.32 – 21.86), showing a statistically significant effect
favoring infection control measures against ESBL-PE infection. The overall effect test
corroborates the results by presenting a p-value less than 0.05 (p = 0.001).
The Relationship between Regions (environmental sources) and ESBL-PE
These meta-analyses included 22 studies that investigated the relationship
between regional sources and ESBL-PE included 15 studies were from the Europe, 4
studies from the Asia and 4 studies from other regions (two from the USA and one from
Australia). The characteristics of studies that participated included in these meta-analyses
are summarized in figure 4,5 and 6, respectively. The random-effect model was chosen
for computing a weighted mean of the effect sizes to determine the effect variation of the
included studies. The combined mean effect sizes for the regional sources of infection
and each ESBL-PE were computed separately. The analyses revealed that the Europe
region and ESBL-PE (r = 0.61, 95% CI [0.32 – 0.91], p = <.0001) were statistically
significant. The combined standard mean effect size for Asia region and ESBL-PE (r =
14.92, 95% CI [9.17 – 20.68], p = <.00001) were statistically significant. Similarly, the
combined standard mean effect size for other regions and ESBL-PE (r = 0.51, 95% CI
[0.36 – 0.67], p = <.00001) were statistically significant too. The tests of homogeneity
effects for the Europe and Asia regional sources of ESBL-PE infection demonstrated that
the studies included in the analyses share a common homogeneity effect size with I2 =
98% (Europe), and I2 = 100% (Asia). While other regions (USA and Australia) with I2 =
63% did not share a common effect size with them.
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The Relationship between types of LTCFs and ESBL-PE
These meta-analyses included 22 studies that investigated the relationship
between LTCFs and ESBL-PE and non-ESBL microorganisms. The characteristics of
studies that participated included in these meta-analyses are summarized in figure 2. The
random-effect model was chosen for computing a weighted mean of the effect sizes to
determine the effect variation of the included studies. The combined mean effect sizes for
the LTCFS sources of infection and each ESBL-PE and non-ESBL were computed
separately. The analyses revealed that the LTCFs, ESBL-PE and non-ESBL (r = 15.78,
95% CI [0.04 – 31.53], p = 0.05) were slightly statistically significant. The tests of
homogeneity effects for the LTCFs sources of ESBL-PE infection demonstrated that the
studies included in the analysis’s homogeneity effect size with I2 = 100%.
The Relationship between Infection Control Measures (ICMs) and ESBL-PE
These meta-analyses included 9 studies that investigated the relationship between
infection control measures (ICMs) and ESBL-PE and non-ESBL microorganisms. The
characteristics of studies that participated included in these meta-analyses are
summarized in figure 7. The random-effect model was chosen for computing a weighted
mean of the effect sizes to determine the effect variation of the included studies. The
combined mean effect sizes for the ICMs against ESBL-PE and non-ESBL were
computed separately. The analyses revealed that the ICMs against ESBL-PE and nonESBL (r = 13.59, 95% CI [5.32 – 21.86], p = 0.001) were statistically significant. The
tests of homogeneity effects for the impact of ICMs on ESBL-PE infection demonstrated
that the studies included in the analysis’s homogeneity effect size with I2 = 99%.
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Risk of Bias
When studies were assessed for risk of bias, I used Newcastle-Ottawa scale, 45%
(n=10) were assessed as having a low risk of bias; 14% (n=3) unclear risk of bias and
41% (n=9) were deemed to have a high risk of bias. An increasing prevalence of ESBLPE trend in all regions of LTCFs over time was also observed, however this increase was
statistical significance.
Multiple Regression Statistics
A supplementary multiple regression analyses have been conducted to analyze the
correlation matrices and standardized regression models of the included meta-analytic
studies. Based on the data provided in included studies for meta-analyses, the
relationships between types of LTCFs, regional (environmental source), infection control
measures and ESBL-PE were analyzed through the SPSS statistical software.
Table 3
Descriptive Statistics

ESBL
LTCFs
Regions
ICMs

Mean
83.18
11.05
11.18
.41

Std.
Deviation
73.591
11.108
5.762
.503

N
22
22
22
22
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Table 4
Model Summary
Adjusted R Std. Error of
Model
R
R Square
Square
the Estimate
a
1
.683
.467
.378
58.037
Note. a. Predictors: (Constant), ICMs, LTCFs, Regions
b. Dependent Variable: ESBL

DurbinWatson
2.152

The Durbin-Watson statistic for this analysis was 2.152. According to Laerd Statistics
(2015), the Durbin-Watson statistic range from 0 to 4. Based on this value, there was
independence of (errors) residuals, as determined by a Durbin-Watson statistic of 2.152.
The R is used to measure the strength of the linear relationship between these two
variables and can signify the goodness of the model fit with a value that can range from 0
to 1. A multiple correlation coefficient of 0 (zero) signifies not linear association between
the dependent variable and the predictor variables and a value of 1 a perfect linear
association. A value of 0.683, indicated a moderate level of relationship between
variables. Though, multiple correlation coefficient, R, is not a commonly used measure to
assess goodness of fit. I observed that R2 was equal to 0.467. This indicated that the
addition of all independent variables into a regression model explained 46.7% of the
variability of dependent variable, (ESBL-PE). The adjusted R2 was 0.378.
Adjusted R2 was used to report value proportion of variance explained (that is, report
37.8% rather than 46.7%) although researcher might be able to report both.
Adjusted R2 is also an estimate of effect size, which at 0.378 (37.8%) is an indication of a
medium effect size according to Cohen's (1988) classification. R2 for the overall model
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was 46.7% with an adjusted R2 of 37.8%, a medium size effect according to Cohen
(1988).
Table 5
ANOVA
Sum of
Model
Squares
df
Mean Square
1
Regression
53097.313
3
17699.104
Residual
60629.959
18
3368.331
Total
113727.273
21
Note. a. Dependent Variable: ESBL
b. Predictors: (Constant), ICMs, LTCFs, Regions

F
5.255

Sig.
.009b

The F-ratio in the ANOVA table above tests whether the overall regression model is a
good fit for the data. "Sig." was observed as the p-value = .009 (i.e., p = .009). the p value
was < .05. This result shows that the independent variables were statistically significantly
predict the dependent variable, F (3, 18) = 3368.33, p <.05; rather than just a p-value.
The breakdown of the last part is as follows, F (3, 18) = 3368.33, p <.05, as shown above
in the ANOVA table. ICMs, LFCFs, and Regions statistically significantly predicted
ESBL-PE, F (3, 15) = 3368.33, p <.05.
Table 6
Coefficientsa
95.0%
Unstandardized Standardized
Confidence
Coefficients
Coefficients
Interval for B
Std.
Lower Upper
Model
B
Error
Beta
t
Sig. Bound Bound
1 (Constant) 68.031 28.771
2.365 .029 7.585 128.476
LTCFs
4.233
1.181
.639
3.585 .002 1.752
6.714
Regions
-3.690 2.390
-.289
.140 -8.712 1.332
1.544
ICMs
23.608 27.776
.161
.850 .407 -34.747 81.964
a. Dependent Variable: ESBL

Collinearity
Correlations
Statistics
Zeroorder Partial Part Tolerance VIF
.627
-.114

.645 .617
-.342 -.266

.933
.845

1.072
1.183

.206

.196

.821

1.218

.146
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According to Hair et al. 2019, the VIF statistic is an alternate to Tolerance (that is, 1
divided by Tolerance resulted in VIF value) but I only need to consult one of these
measures. In this data analysis, all the Tolerance values exceeded 0.1, and the lowest is
0.821. So, with this value, I have no problem with collinearity in this data set. If the
Tolerance value is less than 0.1, I might have a collinearity problem (Hair et al., 2019).
The coefficient for LTCFs was 4.233. The slope coefficient value was positive and
showed that the more of the LTCFs could be associated with prevalence of ESBL-PE.
The multiple regression equation predicts that the more we have residents in the LTCFs
the likely that they would be infected with the ESBL-PE. The 95% confidence interval
(CI) is between 1.752 and 6.714. That is, I can be 95% confident that the true value of the
slope coefficient is between 1.752 and 6.714. I can observe that the p-value was .002
(i.e., p = .002). The p was less than .05. the slope coefficient is statistically significant.
This means that there is a linear relationship between LTCFs and ESBL-PE. Similarly,
the coefficient for regions was -3.690. The 95% confidence interval (CI) was between 8.712 and 1.332. That is, I can observe that the p-value was .140 (i.e., p = .140).
The p was greater than .05. the slope coefficient is not statistically significant. This
means that there was no linear relationship between regions and ESBL-PE. Likewise, the
coefficient for ICMs was 23.608. The 95% confidence interval (CI) was between -34.747
and 81.964. That is, I can be 95% confident that the true value of the slope coefficient
is between -34.747 and 81.964. A link between the 95% confidence interval (CI) of the
slope coefficient and the statistical significance of the slope coefficient can be used to
determine a statistically significant slope coefficient in this case. The confidence intervals
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under this circumstance do cross the zero (0) (-34.747 and 81.964), it showed that there
was no statistically significant slope coefficient (p >.05) between ICMs and ESBL-PE. I
can observe that the p-value was .407 (i.e., p = .407). The p was greater than .05. the
slope coefficient is not statistically significant. This means that there was no linear
relationship between ICMs and ESBL-PE.
Summary
I performed a quantitative meta-analysis on eligible 22 researched studies to
describe the relationship between the variables of interest. A meta-analytical analysis was
performed to summarize large amounts of information about the prevalence and infection
control measures against ESBL-PE among residents in LTCFs, identified gaps in those
studies, and identified interventions useful for the public health community and
policymakers. The studies characteristics were examined, and I found studies from
Europe to be 68.1% (n=15), Asia18.2% (n=4), North America 9.1% (n=2), and Australia
4.5% (n=1). In most of the studies, 40.9% (n=9) followed a cross-sectional design, 27.2%
(n=6) followed point prevalence study, and 18.2% (n=4) followed screening respectively,
while each study including observational cohort, nested case-control study, and
retrospective were (4.5%; n=1) respectively. The duration of included studies ranged
from 0 to 107 months. The populations of the included studies were residents of both
sexes who resided in LTCFs. Heterogeneity confirmed by a high I2 value of = 100% and
a significantly associated p-value (<0.00001). The I2 values represented the percentage of
the total variation, which was due to variation between studies. These regional forest plot
studies in Figures 4, 5, and 6 were conducted to determine the relationship between the
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environmental (regions) source of the LTCFs and ESBL-PE. Multiple regression analysis
also reported LTCF to be linear associated with ESBL-PE (p = .002), regions and ICMs
were not associated with ESBL-PE (p = .140), (p = .407) respectively. Adjusted R2
estimated the effect size at 0.378 (37.8%) proved to be an indication of a medium effect
size of this regression study according to Cohen's (1988) classification. The results
obtained in this chapter provided discussions, conclusion, and recommendations in
chapter 5.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this study was to gather all available empirical research about the
relationship between the LTCFs, the geographical location of LTCFs, ICMs, and ESBLPE. The geographical location of LTCFs was regarded as the regions in which the studies
were conducted. The LTCFs were regarded as the facility in which residents were
residing. The infection control measures were targeted, or untargeted infection control
measures implemented during the studies. Quantitative meta-analyses were conducted to
analyze data for the presence of these relationships. The supplementary statistic
technique, multiple regression statistics were used to find relationships between
independent variables and dependent variable. The meta-analysis results demonstrated
that all regional sources' combined standard mean effect size was statistically
significantly associated with ESBL-PE. The analyses for the Europe region and ESBL-PE
(r = 0.61, 95% CI [0.32 – 0.91], p = <.0001) revealed to be statistically significant
related. The combined standard mean effect size for Asia region and ESBL-PE (r =
14.92, 95% CI [9.17 – 20.68], p = <.00001) were also statistically significant related.
Equally, the combined standard mean effect size for other regions and ESBL-PE (r =
0.51, 95% CI [0.36 – 0.67], p = <.00001) were statistically significant related too. The
analyses of relationship between LTCFs and ESBL-PE and non-ESBL (r = 15.78, 95%
CI [0.04 – 31.53], p = 0.05) were slightly statistically significant related. In like manner,
the analyses of ICMs and ESBL-PE and non-ESBL also revealed (r = 13.59, 95% CI
[5.32 – 21.86], p = 0.001) to be statistically significant related. The results obtained after
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performing multiple regression analyses were demonstrated to be different from the
previous reports. The analysis reported for LTCFs showed a linear associated with
ESBL-PE (p = .002), whereas regions (environmental sources) and ICMs were not
statistically significant (p = .140), (p = .407) respectively.
Interpretation of Findings
The 22 studies included in the analysis of a total of 10570 participants from
studies between 2008 and 2018. Fifteen studies were conducted in Europe (three each in
France and Netherlands, two each in Belgium and the UK, one each Sweden, Portugal,
Germany, Poland, and Italy), four studies were conducted in Asia (two in Japan, one in
China and one in Lebanon), while three studies were performed in other regions, these
include (two in USA and one in Australia). Non studies included from Africa continent.
The pooled prevalence of ESBL-PE colonization among LTCF residents in this metaanalytic study was 15.78% (95% CI 0.04 – 31.53). The ESBL-PE colonization rate in
Europe was 61% (95% CI: 0.32 – 0.91), in Asia was 14.92% (95% CI: 9.17 – 20.68) and
was 51% in other regions, these include the USA and Australia (95% CI: 0.35 – 0.67).
Nine (9) of the 22 studies implemented targeted and untargeted ICMs, including
screening and 13.5% colonization rate was revealed with (95% CI: 5.32 – 21.86). In
meta-analysis, LTCFs was the only statistically significant association with an increase
prevalence of ESBL-PE among residents (p= 0.05). In the supplement statistical
technique, the multiple regression analysis, the regional differences (p = 0.140) and
implementation of ICMs (p = .407) were not statistically significant. However, multiple
regression analysis also reported LTCF to be linear associated with ESBL-PE (p = .002),
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whereas regions (environmental sources) and ICMs were not significantly associated with
ESBL-PE (p = .140), (p = .407) respectively. Methods including screening to control the
prevalence of ESBL-PE were reported in 9 of the 22 reviewed papers, as plotted in figure
7. Three studies reported that ESBL general screening were performed, 2 studies
conducted Infection risk scan (IRIS) control measures, whereas four different studies
performed control measure in each of these methods genomic surveillance, hand hygiene,
national guidelines for empirical therapy, and Close Proximity Interactions (CPIs)
network.
Discussion
LTCFs with the colonization of ESBL-PE among residents have raised concern
due to their impact on morbidity and mortality and the potential for transmitting resistant
enzymes across and within the residential homes (Doi et al., 2017). In most ESBL-PE
studies, the colonization rate has spread globally, and almost one in five LTCF residents
was colonized with the ESBL infection (Flokas et al., 2017). Urinary tract infection (UTI)
has been attributed to the most common infection site among residents in LTCFs and is
the most common reason for prescribing antibiotics in LTCFs (Nicolle, 2001). UTIs' risk
factors include residents with an indwelling catheter, benign prostatic hypertrophy
and prostatitis in men, and estrogen deficiency in women (Nicolle, 2001). With attention
to the fact that residents residing and extensively used healthcare facilities as their day-today caring (Caljouw et al., 2014) can disseminate resistant enzymes to other residents'
populations (van den Dool et al., 2016). Significantly, this could further cause negative
implications for public health because of the proxy nature of most care homes that may
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further spread the disease. Concerning the geographical variability of the studies that I
included in this analysis, most studies were performed in Europe. In contrast, a smaller
number of studies were conducted in North America and Australia. In this study, the
finding signified that ESBL-PE prevalence rates in developed nations are alarming.
Comparatively, there was not enough data to be retrieved from developing countries,
especially the Africa continent. The relative lack of data from the developing country
may result from the fact that LTCFs in many developing countries provided home care
service for their elderly parents at home instead of at formal institutions (World health
organization, 2020). However, retrieval of ESBL data is also underrepresented in specific
regions, for instance, Oceania and North America. The underrepresentation of different
geographical areas may likely lead to an inaccurate worldwide ESBL-PE colonization
rate. In this analysis, ESBL-PE colonization was associated with the LTCFs. Though,
unguided use of the antibiotic, history of recent hospitalization, and urinary catheter use
are risk to ESBL-PE, the gastrointestinal tract also serves as the main reservoir for ESBLPE, and infection with this type of organism is a vital risk factor for consequent disease
in patients. As can be seen, the risk factors mentioned above for ESBL-PE conditions
are repeatedly detected among residents in the LTCFs (Caljouw et al., 2014).
Unfortunately, antibiotics are commonly prescribed unguided in this setting (Flokas et al.,
2017).
Limitations of the Study
Although meta-analyses were essential in all estimates on the overall effect, the
results were only based on a limited number of studies provided for this analysis. I
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acknowledged the selection bias in the included studies, this could cause a limit to the
study since both high risk of bias (n =5) and unclear risk of bias (n=4) were reported to
be 41% and only included studies written in the English language for this analysis. So, it
is likely that my review missed data of interest written in other languages. The study
quality evaluation was performed on different research designs, including cross-sectional,
point prevalence surveys, case-control, and cohort study based on applying the quality
evaluation tool available. The dangers of combining results from cohort studies is that the
study population among cohort studies are more likely to be heterogeneous (Russo 2007).
Data from the Africa continent were not available in this study and limiting the
generalizability of our findings. A limited number of studies with targeted infection
control measures were included in this study, limiting the generalizability of the infection
control's impacts on this patient population.
Recommendations
There are several gaps in the knowledge around this meta-analysis study on
prevalence of ESBL-PE in LTCFs research. The study aimed was to identify relationship
between LTCFs, geographical location and impact of infection control measures and
ESBL-PE. Though limited data were retrieved for the meta-analysis, the prevalence of
ESBL-PE is linked with all the independent variables with infected residents. The
supplement statistical analysis, multiple regression, used in this study only showed a
strong linked between LTCFs and ESBL-PE. Hence, I recommended that more
methodological work is needed to be employed to cover data from all regions to increase
confidence in the generalizability of the study. Although meta-analytical method is
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challenging, it would be especially useful to conduct data that involved targeted infection
control measures to quantify the impact of these measures on residents who are at risk of
acquiring ESBL-PE colonization. It would also be helpful to capture residents who have
had previous hospitalization to determine the rate at which ESBL-PE transmit from
hospital to residential care homes and vice-versa. Future research should also be
developed to carry out a full comparative analysis between hospital patients and residents
acquired ESBL-PE colonization.
Implications
Various studies have shown a higher prevalence of ESBL species in LTCFs,
especially in nursing homes. This is due to inefficient infection prevention practices,
geographical location differences, proximity among the residential homes, and excess use
of antibiotics (Pelly et al., 2006). Healthcare professionals have an essential role in
controlling the spread of ESBL-PE in LTCFs. However, the implementation of targeted
infection control protocols based on evidence-based practices must always be carried out.
Importantly, adequate knowledge of the Enterobacteriaceae organism's ability to resist
beta-lactam antibiotics in the hospital, community, and LTCFs are fundamental in the
provision of efficient healthcare. This dissertation also revealed that appropriate training
programs aimed at developing necessary skills to provide healthcare staff with the ability
to achieve these targets. The training programs should facilitate any potential defects in
advanced practice to reduce or control the spread of ESBL-PE. The detection of ESBL
organisms could be challenging because of differences among the ESBL species and their
ability to spread rapidly among the residents. The antibiotics, such as carbapenems agents
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that are still sensitive to ESBL infections, should only be used in acute health cases to
limit or control further spread of ESBL producing species (Rawat & Nair, 2010). The
positive social change is to promoting awareness for the residents in long-term care
facilities so that the care sites at most risk could take further steps to reduce the risks of
infecting the residents.
Conclusion
In this dissertation, I have reviewed, collated, examined, and assessed ESBL-PE
prevalence among residents in LTCFs. The overall research findings have contributed
insight and new knowledge to understand the current epidemiology of ESBL among
residents in LTCFs of each region. The research provides evidence of the current state of
ESBL-PE globally. It makes available information on how Enterobacteriaceae produced
beta-lactam enzymes to cross-resist empirical antibiotics for patient's treatment. For that
reason, the findings apply to the United Kingdom (UK) and all over the world. The
research undertaken has been especially timely because it coincided with the UK fiveyear antimicrobial resistance strategy from 2014 to 2018 (Global and Public Health
Group, 2017). It was also aligned with the UK public health agency's aims and objectives
of establishing the Healthcare-Associated Infection and Antimicrobial Stewardship
Improvement Board of 2016 in Northern Ireland. This development will inform the
multisectoral collaboration to organize its systems to achieve effective action against the
spread of ESBL-PE, which can be interpreted into practice. I hoped that the
recommendations I suggested in this research, based on the research undertaken, can be
instituted to maintain strict adherence to effective infection control measures.
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Appendix A: Characteristics of Included Studies
Author
&
Year

Country

Design

LTCF
Settings

Risk
of bias

Number of
Residents
assessed

Assessment
period
(month/s)

Number of
ESBL-PE
isolated

ESBL-PE
prevalence
(P%)

Arnoldo et al.,
2013

Italy

23 LTCFs

Low

211

107

114

54.0

Arvand et al.,
2013
Bastard et al.,
2020
Blom et al.,
2016
Brodrick at
al., 2017
Duarte et al.,
2017
Duval et al.,
2019

Germany

Point
prevalence.
surveys (PPS)
Screening

11 NHs

Low

240

13

23

9.58

Control not
reported
(CNR)
CNR

France

PPS

2 NHs

High

144

NR

10

6.9

CNR

Sweden

10 NHs

3

10

10.99

CNR

1 LTCFs

Uncle
ar
Low

91

UK

Cross-sectional
comparison
Cohort

45

6

17

38.0

Portugal

Screening

1LTCF

Low

27

4

6

22.2

genomic
surveillance
CNR

France

PPS

1LTFs

High

329

4

55

16.7

Jallad et al.,
2015
Jans et al.,
2013

Lebanon

Cross-sectional

2 NHs

208

4

149

71.6

Belgium

Cross-sectional
prevalence

41 NHs

Uncle
ar
High

2610

5

205

8.0

Latour et al.,
2019
Lautenbach et
al., 2012
Lim et al.,
2014

Belgian

Crosssectional
Cross-sectional
study
Nested casecontrol study

29 NHs

High

1423

5

168

11.8

National
guidelines
for empirical
therapy
Screening

3 LTCFs

Uncle
ar
High

239

31

8

3.34

CNR

112

NR

12

10.71

CNR

USA
Australia

4 LTCFs

Infection
control
measure

Close
Proximity
Interactions
(CPIs)
network
CNR

112

Luvsansharav
et al., 2013
McKinnell et
al., 2020
Naf et al.,
2017

Japan

Screening

3 NHs

High

225

7

49

21.78

CNR

USA

PPS

28 NHs

Low

1400

12

244

16.0

CNR

France

PPS

23 NHs

Low

680

1

99

14.5

Overdevest et
al., 2016

Netherlands

Cross-sectional
surveys

3 LTCFs

High

296

14

188

17.9

Pobiega et al.,
2013

Poland

3 RCHs &
2 NHs

Low

217

12

14

13.9

Rooney et al.,
2009
van Dulm et
al., 2019

UK

PPS &
prospective
infection
control
Retrospective

Rectal
swabbing
screening
Hand
hygiene, and
improved
cleaning
strategies
CNR

16 NHs

Low

294

12

119

40.48

CNR

Netherlands

Cross-sectional

12 LTCFs

High

385

10

50

12.98

Willemsen et
al., 2014.

Netherlands

Cross-sectional
survey

9 NHs

High

643

2

70

10.88

Yokoyama et
al., 2018
Zhao et al.,
2015

Japan

Screening

9 SNHs

Low

100

5

57

57.0

China

Cross-sectional

7 NHs

Low

390

3

183

46.92

Infection
risk scan
(IRIS
Infection
prevention
Risk Scan
(IRIS)
Screening of
ESBL‐E
CNR

CNR- Control not Reported; ESBL-PE- Extended-spectrum β-lactamase-Producing Enterobacteriaceae; RCHs- Residential Care Homes; IRIS - Infection control
Risk Infection Scan; NHs – Nursing Homes; SNHs - Specialist Nursing Homes.
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